Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
ASTRO.synaptic_interaction: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 2,266 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vaccination | IMMUN000085 | 42.66 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 2 | Heart rate, exercise | CARDI000017 | 42.38 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 3 | MAP2K6/NT5C3A ratio | PRORT001486 | 38.60 | Protein ratios | Muscle / cardiac | 12 | 6 | 8 | 16 | |
| 4 | Viral hepatitis | IMMUN000076 | 36.34 | Immunologic | Neural / glial | 3 | 4 | 10 | 17 | |
| 5 | Social activity, none | SOCIO000018 | 35.25 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 6 | MIA levels | PROLV001311 | 35.00 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 7 | SORCS2 levels | PROLV001919 | 30.19 | Protein levels | Neural / glial | 6 | 1 | 7 | 5 | |
| 8 | Depression or anxiety | PSYCH000025 | 29.40 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 9 | Consultant specialty, anaesthetics | MISCL000015 | 28.97 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 10 | Brain MRI signal intensity | NIMAG000003 | 28.03 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 11 | Smoking dependency | PSYCH000047 | 27.57 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 12 | Pain, none | MSKEL000041 | 27.47 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 13 | Residential stability | SOCIO000014 | 26.46 | Socioeconomic | Neural / glial | 3 | 4 | 7 | 9 | |
| 14 | PDGFB/VEGFC ratio | PRORT001652 | 25.80 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 15 | PDGFB/ST6GAL1 ratio | PRORT001647 | 25.31 | Protein ratios | Neural / glial | 12 | 6 | 11 | 24 | |
| 16 | Sleep behaviour | BEHAV000016 | 24.65 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 17 | Hypothyroxinemia | ENDOC000022 | 24.15 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 18 | LTBP2/MYOC ratio | PRORT001464 | 24.06 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 19 | Psychiatric care | PSYCH000015 | 23.86 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 20 | Housing type | SOCIO000013 | 23.77 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 21 | Worry | PSYCH000032 | 23.74 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 22 | Housing tenure | SOCIO000012 | 23.51 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 23 | Educational attainment, none | SOCIO000001 | 23.42 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 24 | Creativity | PSYCH000003 | 23.25 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 25 | Abdominal and pelvic pain | GASTR000043 | 22.94 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 26 | Chronic illness or disability | MISCL000004 | 22.59 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 27 | Daytime napping | BEHAV000015 | 22.16 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 28 | PLXNA4/SPRY2 ratio | PRORT001685 | 21.65 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 29 | Joint injection | MSKEL000048 | 21.65 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 30 | Mental distress | PSYCH000014 | 21.57 | Psychiatric | Muscle / cardiac | 2 | 7 | 11 | 20 | |
| 31 | Erectile dysfunction | VASCU000048 | 21.46 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 32 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 20.82 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 33 | GPKOW levels | PROLV000925 | 20.79 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 34 | Social support | SOCIO000022 | 20.37 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 35 | Frailty, general | MISCL000039 | 20.36 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 36 | Transport mode | BEHAV000009 | 19.89 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 37 | PPBP levels | PROLV001604 | 19.84 | Protein levels | Neural / glial | 68 | 3 | 9 | 15 | |
| 38 | Pain, multi-site | MSKEL000038 | 19.79 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 39 | PPP1R14A levels | PROLV001614 | 19.72 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 40 | Abnormal heart sounds | CARDI000051 | 19.61 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 41 | NPPB levels | PROLV001424 | 19.60 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 42 | NT5C3A/SCRN1 ratio | PRORT001603 | 19.53 | Protein ratios | Neural / glial | 12 | 5 | 6 | 20 | |
| 43 | Pain, limb | MSKEL000037 | 19.34 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 44 | Reproductive timing | BEHAV000011 | 19.32 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 45 | Meat preference | DTSUP000015 | 19.18 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 46 | Supplement use, mineral or vitamin, none | DTSUP000027 | 19.07 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 47 | DECR1/FXN ratio | PRORT000881 | 18.01 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 48 | RPN1 levels | PROLV001754 | 17.93 | Protein levels | Hepatocyte | 2 | 3 | 8 | 15 | |
| 49 | HGF levels | PROLV000965 | 17.92 | Protein levels | Neural / glial | 29 | 4 | 13 | 15 | |
| 50 | COL6A3/SPON2 ratio | PRORT000701 | 17.55 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 51 | STX16 levels | PROLV001967 | 17.54 | Protein levels | Muscle / cardiac | 7 | 4 | 5 | 17 | |
| 52 | Cortical thickness | NIMAG000010 | 17.52 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 53 | Neuroticism | PSYCH000034 | 17.35 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 54 | Sexual behaviour | BEHAV000012 | 17.15 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 55 | Dietary change, none | DTSUP000005 | 16.92 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 56 | MGAT2 levels | PROLV001308 | 16.77 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 57 | Ataxia | NEURO000013 | 16.76 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 58 | GRAP2/PPP1R2 ratio | PRORT001243 | 16.70 | Protein ratios | Hepatocyte | 7 | 2 | 7 | 16 | |
| 59 | RGMB levels | PROLV001729 | 16.59 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 60 | Frailty, limited social support | SOCIO000017 | 16.51 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 61 | DCTN1/SCAMP3 ratio | PRORT000873 | 16.44 | Protein ratios | Neural / glial | 15 | 4 | 12 | 24 | |
| 62 | FSTL3 levels | PROLV000831 | 15.89 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 63 | Paroxysmal neurological disorder | NEURO000035 | 15.89 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 64 | Smoking behaviour | PSYCH000046 | 15.85 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 65 | Eye disorder, none | OPHTH000007 | 15.57 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 66 | Self-rated health | MISCL000013 | 15.45 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 67 | ERN1 levels | PROLV000730 | 15.43 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 68 | PDGFB/TNFSF13 ratio | PRORT001649 | 15.39 | Protein ratios | Neural / glial | 1 | 5 | 15 | 31 | |
| 69 | Pregnancy complication, premature | REPRO000033 | 15.35 | Reproductive | Neural / glial | 4 | 2 | 6 | 13 | |
| 70 | Pregnancy termination | BEHAV000010 | 15.27 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 71 | Disability allowance, none | SOCIO000016 | 15.12 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 72 | MNX1 levels | PROLV001330 | 15.05 | Protein levels | Neural / glial | 0 | 2 | 6 | 13 | |
| 73 | Social activity | SOCIO000020 | 14.90 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 74 | Fatty acids, stearic acid | LIPID000028 | 14.68 | Lipids | Hepatocyte | 0 | 2 | 5 | 9 | |
| 75 | CD302/CD99 ratio | PRORT000437 | 14.52 | Protein ratios | Neural / glial | 26 | 5 | 13 | 23 | |
| 76 | PFDN5 levels | PROLV001539 | 14.48 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 77 | Suicidal behaviour | PSYCH000037 | 14.45 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 78 | Frailty, disability | MISCL000038 | 14.28 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 79 | Dietary change | DTSUP000006 | 14.23 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 80 | Taste preference | DTSUP000023 | 14.06 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 81 | DPP7 levels | PROLV000648 | 13.95 | Protein levels | Muscle / cardiac | 129 | 4 | 14 | 27 | |
| 82 | ASAH1 levels | PROLV000149 | 13.95 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 83 | Negative affect | PSYCH000030 | 13.93 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 84 | DDAH1 levels | PROLV000607 | 13.90 | Protein levels | Myeloid | 3 | 7 | 10 | 19 | |
| 85 | COMP/THBS4 ratio | PRORT000714 | 13.89 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 86 | LSP1 levels | PROLV001238 | 13.76 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 87 | Professional qualification | SOCIO000003 | 13.73 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 88 | NEFL levels | PROLV001389 | 13.69 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 89 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 13.67 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 90 | Household income | SOCIO000026 | 13.66 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 91 | ZNRF4 levels | PROLV002214 | 13.65 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 92 | CLEC1B/MPIG6B ratio | PRORT000644 | 13.63 | Protein ratios | Myeloid | 4 | 4 | 12 | 13 | |
| 93 | Ocular alignment disorder | OPHTH000023 | 13.63 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 94 | Mood symptoms | PSYCH000029 | 13.52 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 95 | Corrective lens use | OPHTH000032 | 13.47 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 96 | Food preparation preference | DTSUP000021 | 13.36 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 97 | Pregnancy complication, abortive | REPRO000027 | 13.35 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 98 | Body mass index, BMI | BMORP000002 | 13.31 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 99 | TBL1X levels | PROLV002001 | 13.28 | Protein levels | Myeloid | 45 | 4 | 6 | 16 | |
| 100 | DAB2/GRAP2 ratio | PRORT000838 | 13.26 | Protein ratios | Myeloid | 11 | 4 | 9 | 17 | |
| 101 | SPINT2/TNFSF13 ratio | PRORT001811 | 13.26 | Protein ratios | Neural / glial | 17 | 6 | 11 | 43 | |
| 102 | AKR1B1 levels | PROLV000072 | 13.06 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 103 | Brain susceptibility | NIMAG000008 | 13.05 | Neuroimaging | Myeloid | 139 | 3 | 7 | 12 | |
| 104 | Dizziness and giddiness | AUDIO000020 | 12.90 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 105 | EDN1 levels | PROLV000676 | 12.84 | Protein levels | Hepatocyte | 33 | 4 | 11 | 22 | |
| 106 | Cancer, Small intestine | MALIG000029 | 12.69 | Malignancy | Neural / glial | 1 | 1 | 5 | 6 | |
| 107 | Pain, chronic | MSKEL000034 | 12.61 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 108 | COL9A1 levels | PROLV000493 | 12.54 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 109 | Retirement wellbeing | SOCIO000027 | 12.54 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 110 | Anxiety | PSYCH000022 | 12.44 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 111 | Alcohol preference | PSYCH000042 | 12.43 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 112 | Epicondylitis | MSKEL000062 | 12.30 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 18 | |
| 113 | LEPR/NTRK2 ratio | PRORT001448 | 12.26 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 114 | Tuberculosis, TB | IMMUN000050 | 12.26 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 115 | Sun exposure | BEHAV000001 | 12.25 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 116 | PF4 levels | PROLV001538 | 12.21 | Protein levels | Myeloid | 34 | 4 | 9 | 18 | |
| 117 | Falling risk | MISCL000040 | 12.09 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 118 | Serine | METAB000029 | 12.06 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 119 | Hearing loss, age-related | AUDIO000006 | 12.06 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 120 | Brainstem volume | NIMAG000017 | 12.01 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 121 | CNPY4 levels | PROLV000473 | 11.99 | Protein levels | Neural / glial | 24 | 6 | 10 | 14 | |
| 122 | CTF1 levels | PROLV000555 | 11.98 | Protein levels | Myeloid | 5 | 2 | 8 | 16 | |
| 123 | CNPY4/STAT5B ratio | PRORT000681 | 11.96 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 124 | CX3CL1/PODXL2 ratio | PRORT000810 | 11.88 | Protein ratios | Vascular | 14 | 3 | 10 | 15 | |
| 125 | Muscular dystrophy | MSKEL000028 | 11.79 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 126 | Connective tissue disorder | MSKEL000060 | 11.77 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 127 | Seafood preference | DTSUP000016 | 11.74 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 128 | Liver fat | HPBIL000023 | 11.72 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 129 | Cholesteryl esters | LIPID000019 | 11.57 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 130 | THTPA levels | PROLV002030 | 11.52 | Protein levels | Neural / glial | 0 | 4 | 9 | 37 | |
| 131 | THOP1 levels | PROLV002028 | 11.41 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 132 | ARSA/GUSB ratio | PRORT000143 | 11.40 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 133 | Endocrine gland disorder | ENDOC000003 | 11.40 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 134 | FAM151A levels | PROLV000760 | 11.35 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 135 | PDGFB levels | PROLV001523 | 11.31 | Protein levels | Myeloid | 60 | 3 | 12 | 14 | |
| 136 | Occupational physical activity | BEHAV000006 | 11.28 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 137 | Cannabis use | PSYCH000045 | 11.25 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 138 | CETN2/PRTFDC1 ratio | PRORT000607 | 11.19 | Protein ratios | Neural / glial | 0 | 4 | 9 | 15 | |
| 139 | CERT/PRTFDC1 ratio | PRORT000606 | 11.17 | Protein ratios | Hepatocyte | 0 | 2 | 6 | 13 | |
| 140 | ADAMTSL5 levels | PROLV000038 | 11.16 | Protein levels | Muscle / cardiac | 9 | 4 | 6 | 14 | |
| 141 | GCG levels | PROLV000866 | 10.96 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 142 | ART3/RGMA ratio | PRORT000145 | 10.96 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 143 | Flavour preference | DTSUP000022 | 10.89 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 144 | Employment status | SOCIO000005 | 10.78 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 145 | Vegetable preference | DTSUP000020 | 10.77 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 146 | Goitre | ENDOC000019 | 10.76 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 147 | NSFL1C/RILP ratio | PRORT001600 | 10.73 | Protein ratios | Neural / glial | 57 | 6 | 11 | 31 | |
| 148 | Snack and fast-food preference | DTSUP000017 | 10.71 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 149 | Alcohol use | PSYCH000043 | 10.66 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 150 | Cereal preference | DTSUP000010 | 10.62 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 151 | HEXIM1/NT5C3A ratio | PRORT001278 | 10.61 | Protein ratios | Hepatocyte | 17 | 4 | 10 | 20 | |
| 152 | Depression | PSYCH000024 | 10.49 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 153 | Heart rate | CARDI000021 | 10.45 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 154 | LYN levels | PROLV001251 | 10.43 | Protein levels | Myeloid | 41 | 2 | 7 | 13 | |
| 155 | BDNF levels | PROLV000191 | 10.38 | Protein levels | Myeloid | 37 | 2 | 8 | 17 | |
| 156 | Polycystic ovary syndrome | REPRO000024 | 10.38 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 157 | ALDH1A1/SORD ratio | PRORT000081 | 10.34 | Protein ratios | Granulosa cell | 9 | 3 | 7 | 20 | |
| 158 | LRPAP1 levels | PROLV001231 | 10.32 | Protein levels | Vascular | 92 | 3 | 8 | 20 | |
| 159 | Sedentary behaviour | BEHAV000008 | 10.11 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 160 | ECHS1 levels | PROLV000671 | 10.08 | Protein levels | Hepatocyte | 32 | 4 | 12 | 21 | |
| 161 | Medication use, pain etc, none | MISCL000032 | 10.03 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 162 | PCDH12 levels | PROLV001505 | 9.99 | Protein levels | Neural / glial | 5 | 2 | 5 | 10 | |
| 163 | Multiple system atrophy | NEURO000020 | 9.98 | Neurologic | Neural / glial | 0 | 3 | 6 | 16 | |
| 164 | EGFLAM levels | PROLV000686 | 9.96 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 165 | CRKL/DBNL ratio | PRORT000762 | 9.87 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 166 | Arm fat percentage | BCOMP000012 | 9.85 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 167 | Waist circumference | BMORP000013 | 9.82 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 168 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 9.76 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 169 | PCDH7 levels | PROLV001507 | 9.75 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 170 | Metabolic syndrome | METBL000015 | 9.75 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 171 | Fat mass | BCOMP000005 | 9.74 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 172 | Inflammation and poor diet | MISCL000001 | 9.70 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 173 | INPP1/NT5C3A ratio | PRORT001359 | 9.69 | Protein ratios | Hepatocyte | 1 | 4 | 9 | 22 | |
| 174 | CHMP6 levels | PROLV000432 | 9.68 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 175 | Maximal oxygen uptake | CARDI000026 | 9.67 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 176 | Dietary preference | DTSUP000008 | 9.58 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 177 | Vehicle ownership | SOCIO000015 | 9.56 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 178 | Physical activity | BEHAV000007 | 9.56 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 179 | Jaw relationship anomaly | DENTA000007 | 9.54 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 180 | Obesity | METBL000008 | 9.53 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 181 | ENO2/SULT1A1 ratio | PRORT001031 | 9.43 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 182 | SEZ6 levels | PROLV001840 | 9.42 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 183 | Electronic device use | BEHAV000017 | 9.31 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 184 | Arthropathy | MSKEL000013 | 9.30 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 185 | White matter lesion volume | NIMAG000027 | 9.26 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 186 | MYOC/RGMB ratio | PRORT001567 | 9.25 | Protein ratios | Vascular | 11 | 2 | 8 | 15 | |
| 187 | Medication, alcohol use disorder | PSYCH000018 | 9.23 | Psychiatric | B / plasma cell | 0 | 5 | 12 | 15 | |
| 188 | CHGA levels | PROLV000426 | 9.14 | Protein levels | Neural / glial | 33 | 2 | 5 | 12 | |
| 189 | LAMA4/PDGFB ratio | PRORT001420 | 9.12 | Protein ratios | Neural / glial | 19 | 3 | 10 | 28 | |
| 190 | FKBP4/WWP2 ratio | PRORT001156 | 9.12 | Protein ratios | Hepatocyte | 10 | 5 | 12 | 18 | |
| 191 | CASP3/SERPINB9 ratio | PRORT000318 | 9.03 | Protein ratios | Lymphocyte | 45 | 6 | 11 | 24 | |
| 192 | SELP levels | PROLV001805 | 9.01 | Protein levels | Neural / glial | 40 | 5 | 8 | 14 | |
| 193 | KLK4 levels | PROLV001156 | 8.97 | Protein levels | Hepatocyte | 34 | 2 | 7 | 11 | |
| 194 | Household size | SOCIO000011 | 8.95 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 195 | Major depressive disorder | PSYCH000027 | 8.94 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 196 | MPIG6B/SUSD1 ratio | PRORT001559 | 8.92 | Protein ratios | Neural / glial | 6 | 3 | 10 | 14 | |
| 197 | Lysophosphatidylcholines | LIPID000054 | 8.91 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 198 | GSTA1/KRT18 ratio | PRORT001249 | 8.88 | Protein ratios | Hepatocyte | 13 | 2 | 7 | 12 | |
| 199 | Infective dermatitis | DERMA000012 | 8.86 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 200 | GP6/SEMA4D ratio | PRORT001236 | 8.84 | Protein ratios | Hepatocyte | 16 | 6 | 13 | 17 | |
| 201 | BAG6/USP8 ratio | PRORT000201 | 8.83 | Protein ratios | Hepatocyte | 4 | 4 | 9 | 21 | |
| 202 | RBP2 levels | PROLV001711 | 8.83 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 203 | Spinal stenosis | MSKEL000078 | 8.83 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 204 | Dyspnoea | RESPI000028 | 8.82 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 205 | Memory disorder | PSYCH000006 | 8.79 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 206 | Frailty, unhealthy lifestyle | BEHAV000002 | 8.77 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 207 | APRT/NSFL1C ratio | PRORT000136 | 8.74 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 208 | PDGFB/SPINT2 ratio | PRORT001646 | 8.72 | Protein ratios | Hepatocyte | 41 | 2 | 6 | 19 | |
| 209 | Pain, back | MSKEL000033 | 8.62 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 210 | BACH1/PDLIM7 ratio | PRORT000197 | 8.59 | Protein ratios | Platelet | 0 | 5 | 9 | 20 | |
| 211 | SESTD1 levels | PROLV001838 | 8.59 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 212 | ANXA3/SERPINB1 ratio | PRORT000108 | 8.59 | Protein ratios | Myeloid | 19 | 3 | 9 | 9 | |
| 213 | Insomnia | PSYCH000038 | 8.54 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 214 | Psoriatic arthritis vs psoriasis | IMMUN000041 | 8.54 | Immunologic | Neural / glial | 7 | 3 | 10 | 12 | |
| 215 | Cognitive function | PSYCH000002 | 8.52 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 216 | CLC/RNASE3 ratio | PRORT000625 | 8.51 | Protein ratios | Myeloid | 7 | 1 | 5 | 9 | |
| 217 | Trauma exposure | PSYCH000054 | 8.49 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 218 | Non-cancer illness burden | MISCL000029 | 8.45 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 219 | ARHGAP25/RNF41 ratio | PRORT000139 | 8.45 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 220 | Educational attainment | SOCIO000002 | 8.44 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 221 | ARHGEF10 levels | PROLV000140 | 8.42 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 222 | Age at onset of walking | NEURO000023 | 8.41 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 223 | CCL13/CCL2 ratio | PRORT000338 | 8.39 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 224 | FABP1/SULT2A1 ratio | PRORT001097 | 8.36 | Protein ratios | Hepatocyte | 10 | 4 | 8 | 18 | |
| 225 | LAT levels | PROLV001184 | 8.35 | Protein levels | Myeloid | 41 | 2 | 5 | 16 | |
| 226 | Osteoarthritis, OA | MSKEL000012 | 8.23 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 227 | Retinal thickness | OPHTH000043 | 8.22 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 228 | TMPRSS5 levels | PROLV002050 | 8.21 | Protein levels | Neural / glial | 55 | 3 | 7 | 17 | |
| 229 | IL7 levels | PROLV001080 | 8.18 | Protein levels | Lymphocyte | 7 | 4 | 10 | 33 | |
| 230 | NOTCH1/TIE1 ratio | PRORT001592 | 8.10 | Protein ratios | Neural / glial | 13 | 3 | 9 | 15 | |
| 231 | Spondylosis | MSKEL000081 | 8.09 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 232 | FABP2 levels | PROLV000752 | 8.01 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 233 | GFAP levels | PROLV000874 | 7.99 | Protein levels | Myeloid | 2 | 3 | 11 | 10 | |
| 234 | Consultant specialty, gastroenterology | GASTR000007 | 7.98 | Gastrointestinal | Neural / glial | 0 | 5 | 12 | 16 | |
| 235 | Leg fat percentage | BCOMP000015 | 7.98 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 236 | Hearing difficulty | AUDIO000012 | 7.94 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 237 | Digital deformity | MSKEL000053 | 7.93 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 238 | GP6/LGALS8 ratio | PRORT001233 | 7.93 | Protein ratios | Hepatocyte | 5 | 5 | 10 | 28 | |
| 239 | KL levels | PROLV001147 | 7.91 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 240 | Hyperparathyroidism | ENDOC000004 | 7.91 | Endocrine | Hepatocyte | 0 | 3 | 8 | 17 | |
| 241 | Bipolar disorder | PSYCH000023 | 7.86 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 242 | FADD/NCK2 ratio | PRORT001106 | 7.83 | Protein ratios | Neural / glial | 6 | 3 | 8 | 14 | |
| 243 | SMOC1 levels | PROLV001899 | 7.83 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 244 | Dietary pattern | DTSUP000007 | 7.82 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 245 | F5 levels | PROLV000747 | 7.82 | Protein levels | Muscle / cardiac | 0 | 3 | 14 | 28 | |
| 246 | Medication, proton pump inhibitor | GASTR000017 | 7.81 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 247 | Medication, hypnotic or sedative | PSYCH000020 | 7.79 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 248 | Lysophosphatidylinositols | LIPID000056 | 7.77 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 249 | Processing speed | PSYCH000008 | 7.77 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 250 | ITGA6/THPO ratio | PRORT001374 | 7.75 | Protein ratios | Hepatocyte | 54 | 2 | 12 | 27 | |
| 251 | MOG/RTBDN ratio | PRORT001552 | 7.75 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 252 | White matter microstructure | NIMAG000013 | 7.75 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 253 | STMN3 levels | PROLV001966 | 7.70 | Protein levels | Myeloid | 1 | 3 | 8 | 19 | |
| 254 | PPP2R2A levels | PROLV001618 | 7.69 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 255 | FGF2 levels | PROLV000794 | 7.67 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 256 | Pain, joint | MSKEL000036 | 7.63 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 257 | MPI levels | PROLV001334 | 7.55 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 258 | PGLS levels | PROLV001545 | 7.48 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 259 | ARSB levels | PROLV000146 | 7.47 | Protein levels | Myeloid | 63 | 5 | 14 | 21 | |
| 260 | HRG levels | PROLV000988 | 7.46 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 261 | SERPINB1/SERPINB9 ratio | PRORT001774 | 7.42 | Protein ratios | Myeloid | 1 | 6 | 11 | 16 | |
| 262 | HS6ST1/MEGF9 ratio | PRORT001301 | 7.40 | Protein ratios | Hepatocyte | 86 | 2 | 6 | 7 | |
| 263 | Depressive symptoms | PSYCH000026 | 7.36 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 264 | NUCB2 levels | PROLV001451 | 7.25 | Protein levels | Muscle / cardiac | 11 | 4 | 6 | 19 | |
| 265 | Dietary restriction | DTSUP000009 | 7.21 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 266 | CCN1 levels | PROLV000301 | 7.21 | Protein levels | Hepatocyte | 100 | 2 | 10 | 18 | |
| 267 | Gait abnormality | NEURO000014 | 7.21 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 268 | PTN levels | PROLV001669 | 7.20 | Protein levels | Hepatocyte | 35 | 5 | 12 | 30 | |
| 269 | Hydrocephalus | NEURO000002 | 7.10 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 270 | Lacrimal disorder | OPHTH000020 | 7.10 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 271 | CSF volume | NIMAG000018 | 7.07 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 272 | ENO2/MGLL ratio | PRORT001026 | 7.05 | Protein ratios | Muscle / cardiac | 7 | 5 | 9 | 30 | |
| 273 | CACNA2D3 levels | PROLV000250 | 7.02 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 274 | Water consumption | DTSUP000004 | 7.01 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 275 | PDGFB/UXS1 ratio | PRORT001651 | 6.99 | Protein ratios | Hepatocyte | 17 | 3 | 9 | 22 | |
| 276 | Brain ventricle volume | NIMAG000016 | 6.95 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 277 | Gut microbial abundance, Alistipes | GASTR000018 | 6.95 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 278 | Alcohol use disorder | PSYCH000044 | 6.92 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 279 | Sweets preference | DTSUP000019 | 6.92 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 280 | GLB1/GUSB ratio | PRORT001215 | 6.91 | Protein ratios | Hepatocyte | 40 | 2 | 8 | 12 | |
| 281 | KLK14 levels | PROLV001154 | 6.91 | Protein levels | Neural / glial | 28 | 1 | 10 | 8 | |
| 282 | PDCD6 levels | PROLV001518 | 6.89 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 283 | Weight | BMORP000015 | 6.85 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 284 | Retinal detachments and defects | OPHTH000039 | 6.84 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 285 | PON3 levels | PROLV001602 | 6.81 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 286 | CRIP2 levels | PROLV000523 | 6.79 | Protein levels | Myeloid | 32 | 5 | 13 | 19 | |
| 287 | DBI levels | PROLV000597 | 6.78 | Protein levels | Stromal / connective | 31 | 5 | 10 | 18 | |
| 288 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 6.76 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 289 | Cortical surface area | NIMAG000009 | 6.74 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 290 | LYN/TACC3 ratio | PRORT001473 | 6.74 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 291 | SERPINE2 levels | PROLV001831 | 6.72 | Protein levels | Myeloid | 49 | 4 | 8 | 13 | |
| 292 | Fatty acids, docosahexaenoic acid | LIPID000020 | 6.72 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 293 | Peripheral neuropathy | NEURO000032 | 6.70 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 294 | Circadian timing | BEHAV000014 | 6.69 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 295 | Skin and soft tissue infection | IMMUN000073 | 6.68 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 296 | CES3 levels | PROLV000407 | 6.67 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 297 | SFTPA2/SFTPD ratio | PRORT001782 | 6.55 | Protein ratios | Epithelial | 11 | 1 | 4 | 4 | |
| 298 | RILPL2 levels | PROLV001735 | 6.54 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 299 | Nerve root disorder | NEURO000030 | 6.51 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 300 | GP5 levels | PROLV000916 | 6.51 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 301 | PODXL2/SCG3 ratio | PRORT001695 | 6.50 | Protein ratios | Hepatocyte | 28 | 1 | 7 | 13 | |
| 302 | Corpus callosum volume | NIMAG000021 | 6.45 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 303 | BAG6/WASF1 ratio | PRORT000202 | 6.43 | Protein ratios | Hepatocyte | 7 | 3 | 11 | 28 | |
| 304 | DNAJA2/SCAMP3 ratio | PRORT000925 | 6.41 | Protein ratios | Hepatocyte | 8 | 4 | 8 | 17 | |
| 305 | Pain, neck and shoulder | MSKEL000039 | 6.41 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 306 | Adjustment disorder | PSYCH000051 | 6.38 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 307 | Medication, macular degeneration | OPHTH000015 | 6.37 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 308 | CTSE levels | PROLV000563 | 6.34 | Protein levels | Gastrointestinal epithelium | 50 | 0 | 5 | 6 | |
| 309 | Cardiovascular age gap | CARDI000001 | 6.34 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 310 | MAVS/RNF41 ratio | PRORT001499 | 6.33 | Protein ratios | Muscle / cardiac | 19 | 5 | 9 | 16 | |
| 311 | SRC levels | PROLV001942 | 6.32 | Protein levels | Platelet | 9 | 5 | 8 | 15 | |
| 312 | Coffee preference | DTSUP000002 | 6.32 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 313 | GRAP2/TYMP ratio | PRORT001247 | 6.30 | Protein ratios | Hepatocyte | 7 | 4 | 11 | 25 | |
| 314 | Fruit preference | DTSUP000012 | 6.27 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 315 | Gut microbial abundance, Prevotella | GASTR000031 | 6.26 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 11 | |
| 316 | Acquired absence of organs | MISCL000027 | 6.26 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 317 | Disability allowance | SOCIO000019 | 6.25 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 318 | MAVS/SCAMP3 ratio | PRORT001500 | 6.23 | Protein ratios | Neural / glial | 0 | 1 | 6 | 22 | |
| 319 | Diabetes, secondary | METBL000032 | 6.22 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 320 | SIAE/SNAP29 ratio | PRORT001785 | 6.20 | Protein ratios | Hepatocyte | 34 | 3 | 13 | 21 | |
| 321 | Hearing aid use | AUDIO000011 | 6.19 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 322 | Medical condition | MISCL000028 | 6.16 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 323 | Auditory performance | AUDIO000009 | 6.15 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 324 | Pregnancy complication, obstructed labour | REPRO000031 | 6.14 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 325 | DNAJA2/PRDX5 ratio | PRORT000924 | 6.13 | Protein ratios | Myeloid | 0 | 4 | 9 | 20 | |
| 326 | Body size, childhood | BMORP000004 | 6.13 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 327 | Cataract | OPHTH000012 | 6.09 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 328 | Grain and bakery preference | DTSUP000013 | 6.09 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 329 | NT5C1A levels | PROLV001439 | 6.08 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 330 | ERBIN levels | PROLV000727 | 6.03 | Protein levels | Neural / glial | 8 | 6 | 6 | 10 | |
| 331 | Restless legs syndrome, RLS | NEURO000012 | 6.03 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 332 | HGF/PDGFB ratio | PRORT001284 | 6.00 | Protein ratios | Hepatocyte | 11 | 2 | 6 | 17 | |
| 333 | GGT1/IL1RL2 ratio | PRORT001213 | 5.97 | Protein ratios | Hepatocyte | 23 | 2 | 11 | 16 | |
| 334 | Soft tissue disorder | MSKEL000069 | 5.97 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 335 | Operation, cardiac | CARDI000046 | 5.97 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 336 | Stimulant use disorder | PSYCH000048 | 5.97 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 337 | CDH1/CST3 ratio | PRORT000546 | 5.96 | Protein ratios | Hepatocyte | 11 | 1 | 7 | 16 | |
| 338 | Menstrual disorder | REPRO000021 | 5.92 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 339 | ATRN levels | PROLV000163 | 5.90 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 340 | Parkinson disease | NEURO000022 | 5.90 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 341 | Alcohol consumption | PSYCH000041 | 5.89 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 342 | Osteopenia | MSKEL000009 | 5.89 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 343 | GOLM2/STC1 ratio | PRORT001223 | 5.88 | Protein ratios | Vascular | 15 | 1 | 5 | 9 | |
| 344 | ASGR2 levels | PROLV000152 | 5.88 | Protein levels | Hepatocyte | 108 | 2 | 8 | 14 | |
| 345 | Ventricular sphericity | CARDI000014 | 5.84 | Cardiac | Muscle / cardiac | 0 | 3 | 8 | 21 | |
| 346 | SIAE levels | PROLV001858 | 5.84 | Protein levels | Lymphocyte | 17 | 3 | 11 | 36 | |
| 347 | White matter volume | NIMAG000028 | 5.81 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 348 | Administrative status | MISCL000021 | 5.81 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 349 | Tumour marker CA125 | MALIG000037 | 5.79 | Malignancy | Melanocyte | 0 | 5 | 12 | 27 | |
| 350 | MED18 levels | PROLV001292 | 5.79 | Protein levels | Myeloid | 23 | 5 | 10 | 12 | |
| 351 | Medication, anti-gout | METBL000025 | 5.79 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 352 | CD40LG levels | PROLV000341 | 5.78 | Protein levels | Myeloid | 31 | 4 | 7 | 15 | |
| 353 | Dairy preference | DTSUP000011 | 5.78 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 354 | CLPS levels | PROLV000463 | 5.77 | Protein levels | Vascular | 68 | 1 | 3 | 10 | |
| 355 | Chest pain | CARDI000052 | 5.76 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 356 | Tryptophan | METAB000030 | 5.76 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 357 | Beverage preference | DTSUP000001 | 5.76 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 358 | RARRES2 levels | PROLV001706 | 5.76 | Protein levels | Myeloid | 81 | 3 | 7 | 10 | |
| 359 | CHI3L1/HSPG2 ratio | PRORT000610 | 5.76 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 360 | FABP1 levels | PROLV000751 | 5.72 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 361 | Urbanicity | SOCIO000029 | 5.70 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 362 | Hearing loss | AUDIO000013 | 5.65 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 363 | ATXN10/SLC27A4 ratio | PRORT000163 | 5.65 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 364 | SERPINI2 levels | PROLV001837 | 5.64 | Protein levels | Pancreatic epithelium | 137 | 0 | 2 | 3 | |
| 365 | CSNK1G2 levels | PROLV000543 | 5.62 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 366 | CPM/PCSK9 ratio | PRORT000731 | 5.60 | Protein ratios | Hepatocyte | 71 | 2 | 8 | 13 | |
| 367 | VSIR levels | PROLV002172 | 5.60 | Protein levels | Myeloid | 41 | 3 | 7 | 11 | |
| 368 | PPIB levels | PROLV001606 | 5.59 | Protein levels | Vascular | 14 | 7 | 12 | 14 | |
| 369 | TST levels | PROLV002117 | 5.58 | Protein levels | Neural / glial | 2 | 2 | 5 | 15 | |
| 370 | ACADSB levels | PROLV000009 | 5.58 | Protein levels | Neural / glial | 22 | 4 | 10 | 20 | |
| 371 | APOF levels | PROLV000125 | 5.58 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 372 | Schizophrenia | PSYCH000036 | 5.57 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 373 | NPDC1/TAFA5 ratio | PRORT001595 | 5.57 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 374 | Subcortical volume | NIMAG000026 | 5.55 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 375 | L3HYPDH levels | PROLV001172 | 5.55 | Protein levels | Myeloid | 37 | 4 | 8 | 12 | |
| 376 | CD38 levels | PROLV000338 | 5.54 | Protein levels | Muscle / cardiac | 53 | 1 | 5 | 6 | |
| 377 | NFASC levels | PROLV001394 | 5.52 | Protein levels | Hepatocyte | 57 | 3 | 12 | 27 | |
| 378 | Arrhythmia | CARDI000018 | 5.52 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 379 | Fatty acids, undecenoic acid | LIPID000030 | 5.52 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 380 | Cervicobrachial syndrome | MSKEL000073 | 5.50 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 381 | EGLN1/FOXO1 ratio | PRORT001002 | 5.49 | Protein ratios | Hepatocyte | 4 | 4 | 10 | 21 | |
| 382 | Commuting transport | SOCIO000004 | 5.48 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 383 | Creatine metabolites | METAB000058 | 5.45 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 384 | NSFL1C/PSMG3 ratio | PRORT001599 | 5.44 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 385 | GALNT10/IGSF3 ratio | PRORT001201 | 5.44 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 386 | CEBPB levels | PROLV000395 | 5.41 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 387 | CD84/GP6 ratio | PRORT000525 | 5.41 | Protein ratios | Hepatocyte | 7 | 5 | 13 | 19 | |
| 388 | MSRA/P4HB ratio | PRORT001561 | 5.40 | Protein ratios | Neural / glial | 24 | 6 | 15 | 25 | |
| 389 | Atrioventricular block | CARDI000028 | 5.39 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 390 | Ceramides | LIPID000065 | 5.38 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 391 | Cutaneous and subcutaneous lipoma | DERMA000001 | 5.37 | Dermatologic | Lymphocyte | 0 | 3 | 13 | 26 | |
| 392 | DBNL/HEXIM1 ratio | PRORT000866 | 5.35 | Protein ratios | Muscle / cardiac | 0 | 2 | 8 | 15 | |
| 393 | DECR1 levels | PROLV000612 | 5.35 | Protein levels | Myeloid | 4 | 1 | 6 | 8 | |
| 394 | JAM2/RGMB ratio | PRORT001396 | 5.33 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 395 | HPSE levels | PROLV000986 | 5.31 | Protein levels | Lymphocyte | 29 | 3 | 8 | 20 | |
| 396 | PON1 levels | PROLV001600 | 5.29 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 397 | ADAMTS15/CLMP ratio | PRORT000024 | 5.28 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 398 | AKT3 levels | PROLV000076 | 5.26 | Protein levels | Platelet | 10 | 5 | 10 | 16 | |
| 399 | LEP levels | PROLV001199 | 5.25 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 400 | RGMB/THY1 ratio | PRORT001738 | 5.25 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 12 | |
| 401 | Grey matter volume | NIMAG000023 | 5.20 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 402 | Hospital admission | MISCL000022 | 5.18 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 403 | Joint disorder | MSKEL000015 | 5.18 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 404 | PPP1R2/USP8 ratio | PRORT001708 | 5.17 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 405 | ACY1/GSTA1 ratio | PRORT000020 | 5.16 | Protein ratios | Hepatocyte | 61 | 3 | 12 | 27 | |
| 406 | IRAK4 levels | PROLV001098 | 5.16 | Protein levels | Stromal / connective | 19 | 4 | 8 | 17 | |
| 407 | COCH levels | PROLV000482 | 5.15 | Protein levels | Hematopoietic progenitor | 30 | 3 | 5 | 13 | |
| 408 | EHD3 levels | PROLV000690 | 5.14 | Protein levels | Stromal / connective | 14 | 5 | 8 | 17 | |
| 409 | Weight-to-muscle ratio | BCOMP000010 | 5.11 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 410 | Uterine or vaginal bleeding | REPRO000044 | 5.11 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 411 | Isoleucine | METAB000024 | 5.10 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 412 | SPINT2 levels | PROLV001933 | 5.10 | Protein levels | Lymphocyte | 39 | 3 | 7 | 18 | |
| 413 | Cardiac imaging | CARDI000011 | 5.09 | Cardiac | Muscle / cardiac | 20 | 2 | 6 | 19 | |
| 414 | Medication, anticoagulant | VASCU000030 | 5.09 | Vascular | Muscle / cardiac | 85 | 2 | 7 | 18 | |
| 415 | GRAP2 levels | PROLV000931 | 5.06 | Protein levels | Platelet | 6 | 7 | 9 | 18 | |
| 416 | PLAUR levels | PROLV001573 | 5.06 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 417 | CUZD1 levels | PROLV000571 | 5.04 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 418 | Brain functional connectivity | NIMAG000002 | 5.02 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 419 | Cortical volume | NIMAG000022 | 5.02 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 420 | Musculoskeletal soft tissue disorder | MSKEL000029 | 5.01 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 421 | PDGF-BB levels | PROLV001521 | 5.01 | Protein levels | Stromal / connective | 0 | 2 | 2 | 5 | |
| 422 | IL6ST/LEPR ratio | PRORT001353 | 5.00 | Protein ratios | Hepatocyte | 42 | 3 | 10 | 13 | |
| 423 | Brain structural connectivity | NIMAG000007 | 4.99 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 424 | Sleep disorder | PSYCH000039 | 4.99 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 425 | NOS3 levels | PROLV001415 | 4.96 | Protein levels | Myeloid | 58 | 5 | 9 | 18 | |
| 426 | CNPY4/ERBIN ratio | PRORT000679 | 4.95 | Protein ratios | Hepatocyte | 19 | 4 | 7 | 19 | |
| 427 | SHMT1 levels | PROLV001857 | 4.95 | Protein levels | Stromal / connective | 0 | 4 | 12 | 30 | |
| 428 | AMY1A or AMY1B or AMY1C levels | PROLV000089 | 4.94 | Protein levels | Pancreatic epithelium | 33 | 0 | 7 | 9 | |
| 429 | NT5C3A levels | PROLV001440 | 4.92 | Protein levels | Stromal / connective | 13 | 6 | 11 | 20 | |
| 430 | PSCA levels | PROLV001655 | 4.92 | Protein levels | Neural / glial | 5 | 1 | 4 | 12 | |
| 431 | Hip circumference | BMORP000011 | 4.90 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 432 | Medication, analgesic | MISCL000034 | 4.88 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 433 | Social and economic stability | SOCIO000028 | 4.88 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 434 | PROK2 levels | PROLV001639 | 4.87 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 435 | Bile acid metabolites | METAB000033 | 4.86 | Metabolites | Hepatocyte | 8 | 1 | 5 | 15 | |
| 436 | IGLL1 levels | PROLV001036 | 4.82 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 437 | LGMN/SPINT2 ratio | PRORT001457 | 4.82 | Protein ratios | Platelet | 0 | 1 | 5 | 7 | |
| 438 | Hospital stay | MISCL000024 | 4.82 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 439 | USP8 levels | PROLV002146 | 4.81 | Protein levels | Platelet | 2 | 5 | 6 | 11 | |
| 440 | CFHR4 levels | PROLV000416 | 4.81 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 441 | CDKN1A levels | PROLV000382 | 4.78 | Protein levels | Vascular | 59 | 1 | 5 | 13 | |
| 442 | Medical device use, CPAP | RESPI000024 | 4.76 | Respiratory | Hepatocyte | 0 | 3 | 6 | 19 | |
| 443 | CCL11/CCL13 ratio | PRORT000334 | 4.76 | Protein ratios | Myeloid | 9 | 2 | 4 | 10 | |
| 444 | Childhood maltreatment | PSYCH000052 | 4.75 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 445 | HMBS/PSMG3 ratio | PRORT001289 | 4.74 | Protein ratios | Hepatocyte | 15 | 4 | 10 | 29 | |
| 446 | CD164/PARK7 ratio | PRORT000389 | 4.73 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 447 | CEP43 levels | PROLV000402 | 4.73 | Protein levels | Myeloid | 8 | 4 | 9 | 17 | |
| 448 | NUDT5/SERPINB1 ratio | PRORT001610 | 4.70 | Protein ratios | Muscle / cardiac | 0 | 5 | 11 | 22 | |
| 449 | Fatty acids, monounsaturated | LIPID000023 | 4.69 | Lipids | Hepatocyte | 1,143 | 2 | 10 | 17 | |
| 450 | Narcolepsy | NEURO000036 | 4.68 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 451 | STAT5B levels | PROLV001959 | 4.67 | Protein levels | Myeloid | 29 | 5 | 12 | 20 | |
| 452 | HARS1 levels | PROLV000952 | 4.66 | Protein levels | Platelet | 8 | 7 | 9 | 16 | |
| 453 | Sepsis | IMMUN000071 | 4.65 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 454 | CPA2 levels | PROLV000502 | 4.65 | Protein levels | Pancreatic epithelium | 57 | 0 | 5 | 5 | |
| 455 | MAP2K6 levels | PROLV001267 | 4.62 | Protein levels | Muscle / cardiac | 13 | 5 | 13 | 22 | |
| 456 | CREG1/GUSB ratio | PRORT000751 | 4.61 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 457 | BTD levels | PROLV000218 | 4.61 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 458 | Intelligence | PSYCH000004 | 4.60 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 459 | BACH1/HEXIM1 ratio | PRORT000195 | 4.57 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 16 | |
| 460 | Movement disorder | NEURO000015 | 4.57 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 461 | COL18A1 levels | PROLV000484 | 4.56 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 462 | PYY levels | PROLV001690 | 4.56 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 463 | Loud music exposure | MISCL000006 | 4.55 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 464 | Choroid plexus volume | NIMAG000020 | 4.54 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 465 | Branched-chain amino acid metabolites | METAB000004 | 4.52 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 466 | Sex-differentiated cardiometabolic traits | MISCL000002 | 4.52 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 467 | ABL1/PDLIM7 ratio | PRORT000010 | 4.50 | Protein ratios | Platelet | 0 | 4 | 6 | 19 | |
| 468 | CD40LG/GP6 ratio | PRORT000451 | 4.48 | Protein ratios | Myeloid | 0 | 1 | 6 | 11 | |
| 469 | TNFSF10 levels | PROLV002075 | 4.48 | Protein levels | Hepatocyte | 153 | 2 | 7 | 11 | |
| 470 | Medication, anti-depressant | PSYCH000019 | 4.48 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 471 | ECG morphology, adjusted | ECGRM000001 | 4.45 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 472 | FADD/GRAP2 ratio | PRORT001103 | 4.45 | Protein ratios | Neural / glial | 1 | 3 | 6 | 9 | |
| 473 | FCER1A levels | PROLV000776 | 4.44 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 474 | Osteopathy | MSKEL000008 | 4.44 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 4 | 18 | |
| 475 | CD209/GP2 ratio | PRORT000397 | 4.44 | Protein ratios | Epithelial | 36 | 0 | 3 | 6 | |
| 476 | CD69/CLEC1B ratio | PRORT000490 | 4.43 | Protein ratios | Myeloid | 19 | 3 | 8 | 16 | |
| 477 | MEGF10 levels | PROLV001293 | 4.41 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 478 | NSFL1C/UBAC1 ratio | PRORT001601 | 4.38 | Protein ratios | Muscle / cardiac | 21 | 2 | 5 | 13 | |
| 479 | PSMG3 levels | PROLV001660 | 4.36 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 480 | Dorsopathy | MSKEL000075 | 4.33 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 481 | COMP/TGFBI ratio | PRORT000713 | 4.32 | Protein ratios | Myeloid | 28 | 3 | 9 | 20 | |
| 482 | AXIN1/BACH1 ratio | PRORT000164 | 4.32 | Protein ratios | Hepatocyte | 13 | 4 | 11 | 22 | |
| 483 | CPXM1/LGMN ratio | PRORT000734 | 4.31 | Protein ratios | Platelet | 10 | 3 | 6 | 11 | |
| 484 | Cancer, Testis | MALIG000031 | 4.30 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 485 | MTHFSD levels | PROLV001347 | 4.28 | Protein levels | Stromal / connective | 2 | 2 | 4 | 9 | |
| 486 | BID levels | PROLV000195 | 4.27 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 487 | CDKN1A/FXN ratio | PRORT000568 | 4.25 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 488 | Vertigo | AUDIO000021 | 4.24 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 489 | CLEC1B levels | PROLV000448 | 4.23 | Protein levels | Lymphocyte | 35 | 2 | 9 | 25 | |
| 490 | Benign neoplasm, Endocrine | MALIG000003 | 4.23 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 491 | SEPHS1 levels | PROLV001812 | 4.23 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 492 | NFKBIE levels | PROLV001399 | 4.20 | Protein levels | Myeloid | 3 | 2 | 8 | 14 | |
| 493 | TANK levels | PROLV001992 | 4.20 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 494 | Mental disorder | PSYCH000013 | 4.19 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 495 | NTPROBNP levels | PROLV001446 | 4.19 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 496 | DNAJA2/HCLS1 ratio | PRORT000921 | 4.18 | Protein ratios | Myeloid | 6 | 4 | 9 | 19 | |
| 497 | CPM levels | PROLV000507 | 4.18 | Protein levels | Myeloid | 138 | 3 | 11 | 11 | |
| 498 | CDKN1A/NCK2 ratio | PRORT000570 | 4.18 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 499 | RARRES2/ST6GAL1 ratio | PRORT001727 | 4.17 | Protein ratios | Myeloid | 42 | 1 | 6 | 8 | |
| 500 | FGFBP3 levels | PROLV000800 | 4.16 | Protein levels | Myeloid | 16 | 5 | 13 | 15 | |
| 501 | ZBTB17 levels | PROLV002210 | 4.14 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 502 | NCK2/VASH1 ratio | PRORT001575 | 4.14 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 21 | |
| 503 | APOC1 levels | PROLV000122 | 4.13 | Protein levels | Myeloid | 58 | 2 | 13 | 19 | |
| 504 | Gut microbial abundance, Lawsonibacter | GASTR000027 | 4.13 | Gastrointestinal | Neural / glial | 0 | 1 | 3 | 6 | |
| 505 | EREG levels | PROLV000728 | 4.13 | Protein levels | Myeloid | 66 | 3 | 11 | 17 | |
| 506 | Ocular refraction | OPHTH000033 | 4.11 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 507 | SCG2 levels | PROLV001784 | 4.11 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 508 | MFGE8 levels | PROLV001307 | 4.10 | Protein levels | Myeloid | 168 | 3 | 13 | 26 | |
| 509 | PLA2G4A/SPINT2 ratio | PRORT001677 | 4.08 | Protein ratios | Myeloid | 16 | 4 | 10 | 23 | |
| 510 | Dihexosylceramides | LIPID000066 | 4.08 | Lipids | Neural / glial | 1 | 1 | 2 | 7 | |
| 511 | Migraine | NEURO000010 | 4.08 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 512 | AXIN1 levels | PROLV000166 | 4.04 | Protein levels | Lymphocyte | 21 | 3 | 7 | 26 | |
| 513 | Physical decline | AGING000005 | 4.04 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 514 | Brain age gap | NIMAG000004 | 4.03 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 515 | Gut microbial abundance, UBA9475 | GASTR000037 | 4.02 | Gastrointestinal | Hepatocyte | 0 | 2 | 8 | 15 | |
| 516 | Brain neuroimaging quality metric | NIMAG000006 | 4.02 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 517 | Substance use | PSYCH000049 | 4.02 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 518 | CASP3 levels | PROLV000268 | 4.02 | Protein levels | Platelet | 26 | 3 | 9 | 10 | |
| 519 | Phosphatidylinositols | LIPID000061 | 4.02 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 520 | PRSS53 levels | PROLV001647 | 4.01 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 521 | CLEC1B/SORT1 ratio | PRORT000650 | 4.01 | Protein ratios | Myeloid | 21 | 3 | 11 | 17 | |
| 522 | IL13RA1 levels | PROLV001047 | 3.99 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 523 | IGSF8/VSIR ratio | PRORT001340 | 3.99 | Protein ratios | Myeloid | 12 | 3 | 8 | 15 | |
| 524 | NT5C3A/PRDX5 ratio | PRORT001602 | 3.95 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 525 | RP2 levels | PROLV001752 | 3.95 | Protein levels | Vascular | 29 | 2 | 8 | 11 | |
| 526 | ECG morphology, unadjusted | ECGRM000002 | 3.95 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 527 | Body fat percentage | BCOMP000004 | 3.93 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 528 | Pulmonary heart disease | CARDI000027 | 3.93 | Cardiac | Hepatocyte | 56 | 3 | 8 | 16 | |
| 529 | HSD11B1 levels | PROLV000993 | 3.92 | Protein levels | Hepatocyte | 168 | 1 | 9 | 13 | |
| 530 | FGF23 levels | PROLV000796 | 3.92 | Protein levels | Myeloid | 10 | 1 | 6 | 12 | |
| 531 | Immunoglobulin deficiency | IMMUN000049 | 3.92 | Immunologic | B / plasma cell | 4 | 2 | 3 | 11 | |
| 532 | Medication use | MISCL000037 | 3.92 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 533 | PRKAR1A levels | PROLV001631 | 3.91 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 534 | DCTN6 levels | PROLV000604 | 3.91 | Protein levels | Vascular | 0 | 4 | 13 | 31 | |
| 535 | KIAA0319 levels | PROLV001137 | 3.91 | Protein levels | Respiratory epithelium | 15 | 0 | 6 | 14 | |
| 536 | IGSF8 levels | PROLV001039 | 3.88 | Protein levels | Myeloid | 0 | 3 | 5 | 15 | |
| 537 | Mood disorder | PSYCH000028 | 3.87 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 538 | LAYN/TNFRSF4 ratio | PRORT001434 | 3.87 | Protein ratios | Myeloid | 8 | 3 | 7 | 11 | |
| 539 | IL18R1 levels | PROLV001056 | 3.86 | Protein levels | Hepatocyte | 88 | 1 | 5 | 7 | |
| 540 | Hearing difficulty, none | AUDIO000005 | 3.85 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 541 | Viral intestinal infection | IMMUN000077 | 3.85 | Immunologic | Hepatocyte | 3 | 1 | 5 | 11 | |
| 542 | ANXA11 levels | PROLV000106 | 3.85 | Protein levels | Stromal / connective | 26 | 2 | 5 | 15 | |
| 543 | CCL16 levels | PROLV000282 | 3.85 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 544 | Legume preference | DTSUP000014 | 3.84 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 545 | IRAK1/NFATC1 ratio | PRORT001368 | 3.84 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 22 | |
| 546 | EGF levels | PROLV000684 | 3.82 | Protein levels | Myeloid | 47 | 2 | 7 | 21 | |
| 547 | Pain, generic | MSKEL000035 | 3.82 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 548 | Nephritis and nephropathy | NEPHR000010 | 3.82 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 549 | ERBB2/GUSB ratio | PRORT001043 | 3.82 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 550 | MVK levels | PROLV001354 | 3.82 | Protein levels | Stromal / connective | 0 | 5 | 9 | 38 | |
| 551 | CLIP2/DAB2 ratio | PRORT000664 | 3.81 | Protein ratios | Hepatocyte | 13 | 4 | 9 | 10 | |
| 552 | Headache | NEURO000009 | 3.81 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 553 | Medication, respiratory | RESPI000007 | 3.80 | Respiratory | Myeloid | 1 | 2 | 6 | 7 | |
| 554 | ACHE levels | PROLV000012 | 3.79 | Protein levels | Hepatocyte | 125 | 2 | 8 | 15 | |
| 555 | Nephrotic syndrome | NEPHR000011 | 3.78 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 556 | Brain functional activity | NIMAG000001 | 3.77 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 557 | PBXIP1 levels | PROLV001501 | 3.77 | Protein levels | Myeloid | 23 | 2 | 6 | 12 | |
| 558 | Drink temperature | DTSUP000003 | 3.76 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 559 | SFRP4 levels | PROLV001846 | 3.75 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 560 | Organic acid metabolites | METAB000067 | 3.75 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 561 | TMEM106A levels | PROLV002046 | 3.74 | Protein levels | Myeloid | 96 | 3 | 13 | 19 | |
| 562 | Fracture fixation | MSKEL000047 | 3.70 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 563 | HPCAL1 levels | PROLV000984 | 3.69 | Protein levels | Myeloid | 26 | 2 | 4 | 14 | |
| 564 | EHMT2 levels | PROLV000691 | 3.69 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 565 | Phospholipid species | LIPID000064 | 3.68 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 566 | SFRP1 levels | PROLV001844 | 3.65 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 567 | ICA1 levels | PROLV001003 | 3.65 | Protein levels | Myeloid | 31 | 2 | 5 | 18 | |
| 568 | SERPINB6 levels | PROLV001825 | 3.65 | Protein levels | Muscle / cardiac | 5 | 5 | 10 | 23 | |
| 569 | PDGFB/SPARC ratio | PRORT001645 | 3.64 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 570 | PDGFA levels | PROLV001522 | 3.64 | Protein levels | Myeloid | 49 | 2 | 8 | 12 | |
| 571 | METAP2 levels | PROLV001304 | 3.62 | Protein levels | Stromal / connective | 8 | 5 | 13 | 36 | |
| 572 | CELA3A levels | PROLV000397 | 3.62 | Protein levels | Pancreatic epithelium | 72 | 0 | 3 | 1 | |
| 573 | GGACT levels | PROLV000880 | 3.60 | Protein levels | Lymphocyte | 3 | 2 | 9 | 28 | |
| 574 | BCR/ICA1 ratio | PRORT000226 | 3.59 | Protein ratios | Hepatocyte | 0 | 1 | 4 | 23 | |
| 575 | CD40LG/TNFSF14 ratio | PRORT000454 | 3.58 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 576 | Risk-taking behaviour | BEHAV000013 | 3.57 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 577 | ESAM/PDGFB ratio | PRORT001064 | 3.54 | Protein ratios | Hepatocyte | 8 | 2 | 9 | 28 | |
| 578 | RRAS levels | PROLV001755 | 3.53 | Protein levels | Lymphocyte | 9 | 2 | 6 | 14 | |
| 579 | SELPLG levels | PROLV001806 | 3.53 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 580 | METAP1D levels | PROLV001303 | 3.53 | Protein levels | Myeloid | 4 | 4 | 7 | 16 | |
| 581 | Intervertebral disc disorder | MSKEL000076 | 3.52 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 582 | Atrial fibrillation and flutter | CARDI000019 | 3.52 | Cardiac | Muscle / cardiac | 758 | 2 | 4 | 8 | |
| 583 | CLEC1B/EGF ratio | PRORT000636 | 3.51 | Protein ratios | Myeloid | 5 | 1 | 8 | 8 | |
| 584 | CDK8_CCNC levels | PROLV000381 | 3.51 | Protein levels | Hepatocyte | 0 | 2 | 8 | 12 | |
| 585 | Temporomandibular joint disorder | MSKEL000022 | 3.51 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 586 | DAG1 levels | PROLV000592 | 3.50 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 587 | COMT levels | PROLV000497 | 3.47 | Protein levels | Vascular | 9 | 6 | 11 | 23 | |
| 588 | UCMA levels | PROLV002135 | 3.46 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 589 | AIFM1/SIRT2 ratio | PRORT000061 | 3.44 | Protein ratios | Hepatocyte | 13 | 1 | 7 | 13 | |
| 590 | Amygdala volume | NIMAG000014 | 3.43 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 591 | ENO2/FXYD5 ratio | PRORT001022 | 3.43 | Protein ratios | Myeloid | 4 | 5 | 13 | 27 | |
| 592 | DNPH1/PDGFB ratio | PRORT000936 | 3.43 | Protein ratios | Hepatocyte | 5 | 4 | 7 | 23 | |
| 593 | LGALS8 levels | PROLV001206 | 3.43 | Protein levels | Vascular | 13 | 3 | 8 | 21 | |
| 594 | Irritable bowel syndrome | GASTR000004 | 3.42 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 595 | Sodium | METAB000050 | 3.42 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 596 | Eye disorder | OPHTH000008 | 3.41 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 597 | Pregnancy complication, general | REPRO000029 | 3.41 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 598 | Delivery | REPRO000004 | 3.40 | Reproductive | Myeloid | 0 | 2 | 5 | 10 | |
| 599 | Supplement use, dietary | DTSUP000024 | 3.40 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 600 | SWAP70 levels | PROLV001983 | 3.39 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 601 | Neurological disorder | NEURO000008 | 3.39 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 602 | BACH1/SNX9 ratio | PRORT000199 | 3.38 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 11 | |
| 603 | INPP1/TBCC ratio | PRORT001360 | 3.38 | Protein ratios | Hepatocyte | 8 | 1 | 7 | 10 | |
| 604 | SARG levels | PROLV001776 | 3.37 | Protein levels | Stromal / connective | 8 | 5 | 10 | 22 | |
| 605 | BCR/PLXNA4 ratio | PRORT000229 | 3.37 | Protein ratios | Lymphocyte | 3 | 1 | 6 | 25 | |
| 606 | SORD levels | PROLV001920 | 3.35 | Protein levels | Hepatocyte | 44 | 1 | 4 | 11 | |
| 607 | CLTA levels | PROLV000466 | 3.34 | Protein levels | Myeloid | 7 | 6 | 11 | 16 | |
| 608 | TGFBI/VASN ratio | PRORT001832 | 3.34 | Protein ratios | Hepatocyte | 27 | 2 | 5 | 4 | |
| 609 | TP53I3 levels | PROLV002091 | 3.33 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 610 | Cholesteryl esters, HDL | LIPID000015 | 3.33 | Lipids | Hepatocyte | 2,085 | 3 | 9 | 17 | |
| 611 | Social relationships | SOCIO000021 | 3.33 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 612 | Operation, gastrointestinal | GASTR000039 | 3.33 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 613 | CLIC5 levels | PROLV000458 | 3.32 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 614 | WAS levels | PROLV002184 | 3.30 | Protein levels | Hepatocyte | 25 | 2 | 6 | 11 | |
| 615 | Aplastic anaemia | HEMAT000004 | 3.30 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 616 | Lysophosphatidylethanolamines | LIPID000055 | 3.30 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 617 | PRKG1 levels | PROLV001633 | 3.29 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 618 | ARHGEF12 levels | PROLV000141 | 3.29 | Protein levels | Hepatocyte | 17 | 1 | 6 | 14 | |
| 619 | CDKN1A/YES1 ratio | PRORT000576 | 3.28 | Protein ratios | Muscle / cardiac | 8 | 4 | 11 | 28 | |
| 620 | Exercise workload | CARDI000024 | 3.27 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 621 | HPCAL1/SERPINB9 ratio | PRORT001299 | 3.27 | Protein ratios | Myeloid | 21 | 4 | 6 | 24 | |
| 622 | CKAP4/IL4R ratio | PRORT000620 | 3.26 | Protein ratios | Hepatocyte | 33 | 2 | 13 | 18 | |
| 623 | FXYD5 levels | PROLV000841 | 3.25 | Protein levels | Myeloid | 24 | 4 | 11 | 19 | |
| 624 | SULT1A1 levels | PROLV001973 | 3.25 | Protein levels | Muscle / cardiac | 31 | 4 | 8 | 23 | |
| 625 | EIF4EBP1 levels | PROLV000697 | 3.24 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 626 | EFEMP1/TGFBR3 ratio | PRORT000988 | 3.24 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 627 | MESD levels | PROLV001301 | 3.23 | Protein levels | Platelet | 9 | 6 | 7 | 11 | |
| 628 | APOH levels | PROLV000126 | 3.23 | Protein levels | Hepatocyte | 2 | 2 | 10 | 17 | |
| 629 | TYMP levels | PROLV002128 | 3.23 | Protein levels | Vascular | 4 | 2 | 8 | 24 | |
| 630 | WFDC5 levels | PROLV002190 | 3.22 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 631 | Chronic viral hepatitis | IMMUN000056 | 3.22 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 632 | CHMP1A/EREG ratio | PRORT000612 | 3.22 | Protein ratios | Myeloid | 33 | 3 | 14 | 21 | |
| 633 | EGF/GP6 ratio | PRORT000994 | 3.21 | Protein ratios | Myeloid | 9 | 2 | 6 | 10 | |
| 634 | F9/RARRES2 ratio | PRORT001093 | 3.21 | Protein ratios | Myeloid | 17 | 2 | 6 | 13 | |
| 635 | Handedness | BEHAV000003 | 3.20 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 636 | ASGR1/DCBLD2 ratio | PRORT000147 | 3.20 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 637 | ITM2A levels | PROLV001120 | 3.20 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 638 | MSRA levels | PROLV001343 | 3.19 | Protein levels | Myeloid | 18 | 2 | 4 | 15 | |
| 639 | Enthesopathy | MSKEL000061 | 3.19 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 640 | CD99/CD99L2 ratio | PRORT000533 | 3.18 | Protein ratios | Hepatocyte | 56 | 1 | 9 | 15 | |
| 641 | CTSL levels | PROLV000566 | 3.18 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 642 | CNTN3 levels | PROLV000477 | 3.17 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 643 | Medication, laxative | GASTR000016 | 3.17 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 644 | Occupational attainment | SOCIO000007 | 3.16 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 645 | Financial satisfaction | SOCIO000024 | 3.16 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 646 | HNRNPK levels | PROLV000982 | 3.16 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 647 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 3.15 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 648 | Fatty acids, eicosatrienoic acid | LIPID000021 | 3.15 | Lipids | Lymphocyte | 2 | 2 | 7 | 13 | |
| 649 | CLPP levels | PROLV000462 | 3.15 | Protein levels | Myeloid | 2 | 4 | 5 | 17 | |
| 650 | MAVS/MYO9B ratio | PRORT001496 | 3.15 | Protein ratios | Myeloid | 0 | 1 | 4 | 16 | |
| 651 | Glycerophosphocholines | LIPID000053 | 3.14 | Lipids | Neural / glial | 0 | 2 | 11 | 17 | |
| 652 | TPP1 levels | PROLV002097 | 3.14 | Protein levels | Myeloid | 47 | 4 | 11 | 16 | |
| 653 | Retinal disorder | OPHTH000040 | 3.13 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 654 | NTF4 levels | PROLV001443 | 3.13 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 655 | TIE1 levels | PROLV002033 | 3.12 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 656 | Glycine | METAB000022 | 3.12 | Metabolites | Hepatocyte | 498 | 1 | 7 | 11 | |
| 657 | CLEC4M levels | PROLV000454 | 3.11 | Protein levels | Myeloid | 48 | 2 | 9 | 20 | |
| 658 | SCARA5/TGFBI ratio | PRORT001759 | 3.10 | Protein ratios | Hepatocyte | 10 | 3 | 6 | 12 | |
| 659 | HYOU1/TGFBR3 ratio | PRORT001317 | 3.08 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 660 | Leucine | METAB000025 | 3.07 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 661 | AGXT/GRPEL1 ratio | PRORT000051 | 3.07 | Protein ratios | Hepatocyte | 44 | 2 | 5 | 11 | |
| 662 | BCR levels | PROLV000190 | 3.07 | Protein levels | Vascular | 29 | 3 | 7 | 17 | |
| 663 | PCSK9 levels | PROLV001512 | 3.05 | Protein levels | Hepatocyte | 87 | 1 | 5 | 8 | |
| 664 | Congenital cardiovascular malformations | CARDI000031 | 3.05 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 665 | PPIE levels | PROLV001607 | 3.04 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 666 | Refractive errors | OPHTH000034 | 3.04 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 667 | Cholesterol, IDL free | LIPID000004 | 3.04 | Lipids | Hepatocyte | 608 | 1 | 9 | 12 | |
| 668 | TNFSF11 levels | PROLV002076 | 3.04 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 669 | DPP6/NRCAM ratio | PRORT000946 | 3.03 | Protein ratios | Epithelial | 13 | 0 | 5 | 7 | |
| 670 | EPHB4/ESAM ratio | PRORT001036 | 3.03 | Protein ratios | Vascular | 32 | 3 | 10 | 22 | |
| 671 | FEN1 levels | PROLV000789 | 3.01 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 672 | CRKL levels | PROLV000526 | 3.01 | Protein levels | Platelet | 7 | 5 | 8 | 18 | |
| 673 | DKK3/LTBP2 ratio | PRORT000908 | 3.01 | Protein ratios | Neural / glial | 1 | 1 | 5 | 13 | |
| 674 | Valine | METAB000032 | 3.01 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 675 | KYAT1 levels | PROLV001169 | 3.00 | Protein levels | Neural / glial | 2 | 2 | 8 | 16 | |
| 676 | ITIH4 levels | PROLV001119 | 3.00 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 677 | SIGLEC8 levels | PROLV001864 | 3.00 | Protein levels | Hepatocyte | 69 | 3 | 10 | 15 | |
| 678 | Cardiomyopathy | CARDI000040 | 3.00 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 679 | VPS4B levels | PROLV002167 | 2.99 | Protein levels | Stromal / connective | 9 | 4 | 8 | 15 | |
| 680 | PRCP levels | PROLV001624 | 2.99 | Protein levels | Myeloid | 18 | 3 | 10 | 18 | |
| 681 | HTRA2 levels | PROLV001000 | 2.98 | Protein levels | Stromal / connective | 9 | 3 | 7 | 14 | |
| 682 | GP2/LGALS8 ratio | PRORT001230 | 2.98 | Protein ratios | Epithelial | 14 | 1 | 4 | 11 | |
| 683 | CRYBB1 levels | PROLV000532 | 2.97 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 684 | Hypertriglyceridaemia | METBL000023 | 2.97 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 685 | GSTA1/SULT2A1 ratio | PRORT001252 | 2.96 | Protein ratios | Hepatocyte | 47 | 3 | 10 | 13 | |
| 686 | Trunk fat percentage | BCOMP000018 | 2.96 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 687 | ANXA4 levels | PROLV000108 | 2.96 | Protein levels | Myeloid | 31 | 2 | 6 | 17 | |
| 688 | CST3/TAFA5 ratio | PRORT000787 | 2.96 | Protein ratios | Myeloid | 1 | 3 | 10 | 9 | |
| 689 | PARK7 levels | PROLV001496 | 2.96 | Protein levels | Lymphocyte | 0 | 5 | 13 | 38 | |
| 690 | HNRNPAB levels | PROLV000981 | 2.96 | Protein levels | Granulosa cell | 11 | 3 | 8 | 17 | |
| 691 | LCAT levels | PROLV001190 | 2.96 | Protein levels | Hepatocyte | 88 | 2 | 8 | 13 | |
| 692 | GUSB levels | PROLV000946 | 2.95 | Protein levels | Hepatocyte | 109 | 2 | 9 | 12 | |
| 693 | PAMR1/RARRES2 ratio | PRORT001620 | 2.95 | Protein ratios | Hepatocyte | 48 | 2 | 7 | 14 | |
| 694 | TNFRSF11B levels | PROLV002061 | 2.95 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 695 | MCEMP1 levels | PROLV001285 | 2.94 | Protein levels | Myeloid | 46 | 3 | 8 | 17 | |
| 696 | Fatty acids unsaturation | LIPID000032 | 2.94 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 697 | SERPINA12 levels | PROLV001816 | 2.94 | Protein levels | Hepatocyte | 63 | 3 | 11 | 18 | |
| 698 | MGMT levels | PROLV001310 | 2.93 | Protein levels | Myeloid | 10 | 4 | 7 | 14 | |
| 699 | XXYLT1 levels | PROLV002201 | 2.93 | Protein levels | Muscle / cardiac | 1 | 2 | 3 | 8 | |
| 700 | HEXIM1/TRIAP1 ratio | PRORT001281 | 2.93 | Protein ratios | Myeloid | 2 | 3 | 17 | 30 | |
| 701 | CCL13/CCL8 ratio | PRORT000339 | 2.92 | Protein ratios | Myeloid | 0 | 2 | 7 | 27 | |
| 702 | MANF/PRDX5 ratio | PRORT001478 | 2.92 | Protein ratios | Myeloid | 2 | 5 | 12 | 16 | |
| 703 | CDKN2D levels | PROLV000383 | 2.91 | Protein levels | Platelet | 10 | 3 | 7 | 17 | |
| 704 | TF levels | PROLV002011 | 2.91 | Protein levels | Hepatocyte | 40 | 3 | 8 | 17 | |
| 705 | APRT/MIF ratio | PRORT000135 | 2.91 | Protein ratios | Lymphocyte | 2 | 4 | 14 | 40 | |
| 706 | F9 levels | PROLV000750 | 2.90 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 707 | HGS levels | PROLV000967 | 2.89 | Protein levels | Stromal / connective | 0 | 3 | 11 | 17 | |
| 708 | GRAP2/LACTB2 ratio | PRORT001240 | 2.89 | Protein ratios | Hepatocyte | 5 | 3 | 7 | 13 | |
| 709 | ECHDC3 levels | PROLV000670 | 2.89 | Protein levels | Hepatocyte | 45 | 2 | 7 | 7 | |
| 710 | Sebaceous gland disorder | DERMA000034 | 2.89 | Dermatologic | Myeloid | 30 | 2 | 9 | 5 | |
| 711 | Eyelid disorder | OPHTH000019 | 2.88 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 712 | CRADD/FADD ratio | PRORT000745 | 2.88 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 713 | Lysine metabolites | METAB000009 | 2.88 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 714 | Atrophic skin disorder | DERMA000037 | 2.87 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 715 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 2.87 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 716 | Birth weight availability | MISCL000005 | 2.85 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 717 | DBNL/DNAJA2 ratio | PRORT000864 | 2.85 | Protein ratios | Muscle / cardiac | 22 | 6 | 15 | 21 | |
| 718 | CCL22/PDGFB ratio | PRORT000351 | 2.84 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 719 | Arterial dissection | VASCU000003 | 2.83 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 720 | Diabetes, type 2 with complication | METBL000033 | 2.83 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 721 | APOL1 levels | PROLV000127 | 2.83 | Protein levels | Hepatocyte | 130 | 1 | 7 | 6 | |
| 722 | RNF146 levels | PROLV001744 | 2.82 | Protein levels | Muscle / cardiac | 0 | 1 | 3 | 18 | |
| 723 | SLC35G2 levels | PROLV001879 | 2.82 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 724 | PLA2G4A levels | PROLV001569 | 2.82 | Protein levels | Platelet | 5 | 3 | 5 | 14 | |
| 725 | Bleeding gums | DENTA000011 | 2.81 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 726 | BCL2L15 levels | PROLV000188 | 2.80 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 727 | Frailty, poorer cognition | PSYCH000001 | 2.79 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 728 | LONP1 levels | PROLV001220 | 2.79 | Protein levels | Myeloid | 20 | 3 | 11 | 20 | |
| 729 | Intestinal disorder | GASTR000012 | 2.79 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 730 | SNX9 levels | PROLV001915 | 2.79 | Protein levels | Vascular | 12 | 1 | 4 | 20 | |
| 731 | KLF4 levels | PROLV001149 | 2.79 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 732 | DAB2 levels | PROLV000591 | 2.78 | Protein levels | Lymphocyte | 6 | 3 | 7 | 19 | |
| 733 | CCN5 levels | PROLV000305 | 2.78 | Protein levels | Vascular | 15 | 0 | 5 | 12 | |
| 734 | Functional gastrointestinal disorder | GASTR000003 | 2.78 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 735 | PLXNB3 levels | PROLV001587 | 2.77 | Protein levels | Muscle / cardiac | 12 | 2 | 6 | 13 | |
| 736 | CHI3L1 levels | PROLV000428 | 2.76 | Protein levels | Hepatocyte | 54 | 1 | 7 | 13 | |
| 737 | CAMKK1/FOXO1 ratio | PRORT000305 | 2.76 | Protein ratios | Muscle / cardiac | 2 | 4 | 13 | 17 | |
| 738 | CLPP/DECR1 ratio | PRORT000672 | 2.76 | Protein ratios | B / plasma cell | 0 | 4 | 9 | 10 | |
| 739 | SNCA levels | PROLV001908 | 2.76 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 740 | CRKL/MGLL ratio | PRORT000765 | 2.75 | Protein ratios | Hepatocyte | 27 | 3 | 9 | 16 | |
| 741 | Liver volume | HPBIL000025 | 2.75 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 742 | Ischaemic stroke | VASCU000015 | 2.74 | Vascular | Muscle / cardiac | 4 | 3 | 8 | 13 | |
| 743 | IDS levels | PROLV001012 | 2.74 | Protein levels | B / plasma cell | 11 | 2 | 5 | 9 | |
| 744 | MYOC/NOTCH3 ratio | PRORT001566 | 2.73 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 745 | Healthspan | AGING000004 | 2.73 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 746 | MNDA levels | PROLV001329 | 2.72 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 747 | EPHB6/LAYN ratio | PRORT001037 | 2.71 | Protein ratios | Muscle / cardiac | 6 | 2 | 3 | 13 | |
| 748 | AKT1S1/MAX ratio | PRORT000065 | 2.71 | Protein ratios | Myeloid | 3 | 3 | 10 | 12 | |
| 749 | WFIKKN1 levels | PROLV002191 | 2.71 | Protein levels | Vascular | 125 | 2 | 7 | 15 | |
| 750 | LDLRAP1 levels | PROLV001195 | 2.71 | Protein levels | Stromal / connective | 2 | 4 | 6 | 13 | |
| 751 | CLEC14A/EPHB4 ratio | PRORT000626 | 2.71 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 752 | AIFM1 levels | PROLV000069 | 2.71 | Protein levels | Myeloid | 10 | 3 | 10 | 17 | |
| 753 | SCARA5 levels | PROLV001780 | 2.71 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 754 | Urticaria | IMMUN000007 | 2.71 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 755 | Ventricular mass | CARDI000012 | 2.69 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 756 | IMMT levels | PROLV001083 | 2.69 | Protein levels | Vascular | 0 | 0 | 6 | 20 | |
| 757 | CTRL levels | PROLV000559 | 2.68 | Protein levels | Hepatocyte | 128 | 1 | 3 | 7 | |
| 758 | LAMA4 levels | PROLV001178 | 2.68 | Protein levels | Vascular | 67 | 2 | 8 | 19 | |
| 759 | Skin pigmentation | DERMA000026 | 2.68 | Dermatologic | Melanocyte | 78 | 1 | 1 | 3 | |
| 760 | FABP1/LGALS4 ratio | PRORT001095 | 2.68 | Protein ratios | Hepatocyte | 27 | 1 | 9 | 21 | |
| 761 | GALNT2 levels | PROLV000849 | 2.67 | Protein levels | Hepatocyte | 132 | 4 | 10 | 18 | |
| 762 | CTRC levels | PROLV000558 | 2.66 | Protein levels | Pancreatic epithelium | 90 | 0 | 1 | 3 | |
| 763 | PLXNA4/SRPK2 ratio | PRORT001686 | 2.66 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 764 | PLTP levels | PROLV001582 | 2.66 | Protein levels | Myeloid | 143 | 4 | 14 | 17 | |
| 765 | AGXT levels | PROLV000060 | 2.66 | Protein levels | Hepatocyte | 122 | 1 | 6 | 9 | |
| 766 | Ventricular function | CARDI000008 | 2.66 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 767 | Neuropathic arthropathy | MSKEL000017 | 2.64 | Musculoskeletal | Myeloid | — | 1 | 7 | 11 | |
| 768 | SERPINB1 levels | PROLV001823 | 2.63 | Protein levels | Myeloid | 23 | 5 | 6 | 19 | |
| 769 | SERPINB1/TMSB10 ratio | PRORT001775 | 2.63 | Protein ratios | Muscle / cardiac | 6 | 3 | 10 | 17 | |
| 770 | SNRPB2 levels | PROLV001910 | 2.63 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 771 | Kidney volume | NEPHR000022 | 2.63 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 772 | TIMM8A levels | PROLV002037 | 2.62 | Protein levels | Vascular | 17 | 4 | 8 | 16 | |
| 773 | MINK1 levels | PROLV001316 | 2.62 | Protein levels | Stromal / connective | 2 | 4 | 6 | 15 | |
| 774 | Diabetes, general | METBL000030 | 2.61 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 775 | ANGPT1 levels | PROLV000093 | 2.61 | Protein levels | Myeloid | 110 | 2 | 9 | 14 | |
| 776 | SCLY levels | PROLV001790 | 2.61 | Protein levels | Hepatocyte | 62 | 2 | 8 | 16 | |
| 777 | MPHOSPH8/USP8 ratio | PRORT001555 | 2.60 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 778 | GP6 levels | PROLV000917 | 2.59 | Protein levels | Myeloid | 21 | 2 | 6 | 18 | |
| 779 | EIF4G1/HEXIM1 ratio | PRORT001010 | 2.59 | Protein ratios | Hepatocyte | 13 | 3 | 8 | 19 | |
| 780 | SEMA3G levels | PROLV001808 | 2.59 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 781 | MAVS levels | PROLV001279 | 2.59 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 782 | CLIP2/NT5C3A ratio | PRORT000667 | 2.58 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 783 | ELOA levels | PROLV000701 | 2.58 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 784 | FGR levels | PROLV000804 | 2.57 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 785 | Frailty, multimorbidity | METBL000012 | 2.57 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 786 | TEK levels | PROLV002009 | 2.57 | Protein levels | Vascular | 153 | 0 | 4 | 11 | |
| 787 | LBP levels | PROLV001188 | 2.57 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 788 | Metabolon metabolite | METAB000076 | 2.57 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 789 | Wheeze | RESPI000034 | 2.57 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 790 | MAVS/MZT1 ratio | PRORT001497 | 2.56 | Protein ratios | Muscle / cardiac | 0 | 4 | 13 | 23 | |
| 791 | C8B levels | PROLV000237 | 2.56 | Protein levels | Hepatocyte | 31 | 3 | 16 | 31 | |
| 792 | ASAH2 levels | PROLV000150 | 2.56 | Protein levels | Myeloid | 115 | 3 | 7 | 17 | |
| 793 | PLXNA4 levels | PROLV001585 | 2.54 | Protein levels | Lymphocyte | 41 | 2 | 5 | 19 | |
| 794 | BCAN/NCAN ratio | PRORT000218 | 2.54 | Protein ratios | Granulosa cell | 5 | 5 | 8 | 16 | |
| 795 | FABP2/RBP2 ratio | PRORT001099 | 2.53 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 796 | NPY levels | PROLV001429 | 2.53 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 797 | CXCL3 levels | PROLV000583 | 2.53 | Protein levels | Stromal / connective | 18 | 2 | 5 | 5 | |
| 798 | NFATC1 levels | PROLV001395 | 2.53 | Protein levels | Myeloid | 34 | 2 | 6 | 12 | |
| 799 | MEP1B levels | PROLV001298 | 2.53 | Protein levels | Hepatocyte | 85 | 1 | 4 | 4 | |
| 800 | EIF4B/MAP4K5 ratio | PRORT001007 | 2.53 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 22 | |
| 801 | Glycine metabolites | METAB000007 | 2.53 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 802 | MANF levels | PROLV001262 | 2.52 | Protein levels | Myeloid | 26 | 4 | 7 | 20 | |
| 803 | Methionine metabolites | METAB000010 | 2.51 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 804 | GDNF levels | PROLV000872 | 2.51 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 805 | GAL levels | PROLV000847 | 2.51 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 806 | ENG levels | PROLV000704 | 2.51 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 807 | Glomerular disease | NEPHR000006 | 2.50 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 808 | ENO1 levels | PROLV000705 | 2.50 | Protein levels | Myeloid | 5 | 4 | 8 | 15 | |
| 809 | NUB1 levels | PROLV001449 | 2.49 | Protein levels | Stromal / connective | 1 | 3 | 7 | 13 | |
| 810 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 2.49 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 811 | Supplement use, mineral or vitamin | DTSUP000026 | 2.49 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 812 | CTSH levels | PROLV000565 | 2.48 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 813 | PCDH9 levels | PROLV001508 | 2.48 | Protein levels | Myeloid | 32 | 2 | 9 | 15 | |
| 814 | CD46/THBD ratio | PRORT000460 | 2.48 | Protein ratios | Vascular | 20 | 2 | 8 | 18 | |
| 815 | SH2B3 levels | PROLV001851 | 2.48 | Protein levels | Myeloid | 29 | 2 | 9 | 12 | |
| 816 | DKK1 levels | PROLV000620 | 2.47 | Protein levels | Myeloid | 37 | 2 | 9 | 12 | |
| 817 | BACH1/EIF4G1 ratio | PRORT000194 | 2.47 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 20 | |
| 818 | Copper | METAB000045 | 2.46 | Metabolites | Muscle / cardiac | 0 | 3 | 6 | 21 | |
| 819 | FADD levels | PROLV000758 | 2.45 | Protein levels | Stromal / connective | 13 | 3 | 5 | 15 | |
| 820 | DAB2/ERBIN ratio | PRORT000835 | 2.45 | Protein ratios | Muscle / cardiac | 0 | 5 | 15 | 36 | |
| 821 | Oesophageal disorder | GASTR000050 | 2.45 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 822 | NUB1/SRPK2 ratio | PRORT001605 | 2.45 | Protein ratios | Myeloid | 0 | 1 | 5 | 8 | |
| 823 | CCL11 levels | PROLV000278 | 2.44 | Protein levels | Vascular | 47 | 0 | 1 | 5 | |
| 824 | ANPEP/NT5E ratio | PRORT000102 | 2.44 | Protein ratios | Vascular | 19 | 0 | 4 | 9 | |
| 825 | TNFRSF14/TNFRSF1A ratio | PRORT001850 | 2.44 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 27 | |
| 826 | TIA1 levels | PROLV002032 | 2.42 | Protein levels | Myeloid | 24 | 2 | 4 | 14 | |
| 827 | NCK2 levels | PROLV001381 | 2.41 | Protein levels | Stromal / connective | 13 | 3 | 7 | 16 | |
| 828 | Birth complication | REPRO000036 | 2.41 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 829 | MGLL levels | PROLV001309 | 2.41 | Protein levels | Platelet | 25 | 2 | 5 | 9 | |
| 830 | CNPY4/MESD ratio | PRORT000680 | 2.39 | Protein ratios | Hepatocyte | 4 | 5 | 10 | 27 | |
| 831 | KYNU/SCLY ratio | PRORT001416 | 2.39 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 832 | CRTAC1 levels | PROLV000529 | 2.38 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 833 | CD84/CDKN1A ratio | PRORT000520 | 2.38 | Protein ratios | Hepatocyte | 12 | 3 | 8 | 16 | |
| 834 | SMAD1 levels | PROLV001894 | 2.37 | Protein levels | Stromal / connective | 1 | 2 | 8 | 11 | |
| 835 | ENG/TNFRSF10C ratio | PRORT001020 | 2.37 | Protein ratios | Neural / glial | 1 | 1 | 6 | 8 | |
| 836 | DEFB4A or DEFB4B levels | PROLV000614 | 2.37 | Protein levels | Hepatocyte | 48 | 1 | 7 | 15 | |
| 837 | LAT2 levels | PROLV001185 | 2.37 | Protein levels | Myeloid | 0 | 3 | 8 | 14 | |
| 838 | CLPS/CTRB1 ratio | PRORT000673 | 2.36 | Protein ratios | Pancreatic epithelium | 20 | 0 | 1 | 6 | |
| 839 | Stressful life events | PSYCH000053 | 2.36 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 840 | PARK7/TNFRSF9 ratio | PRORT001621 | 2.36 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 841 | GP1BA levels | PROLV000913 | 2.35 | Protein levels | Myeloid | 60 | 5 | 12 | 17 | |
| 842 | DOK2 levels | PROLV000642 | 2.35 | Protein levels | Platelet | 24 | 4 | 9 | 11 | |
| 843 | LACTB2 levels | PROLV001174 | 2.35 | Protein levels | Platelet | 2 | 3 | 9 | 25 | |
| 844 | NFATC1/SPRY2 ratio | PRORT001586 | 2.34 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 32 | |
| 845 | PRTFDC1 levels | PROLV001649 | 2.34 | Protein levels | Platelet | 28 | 3 | 11 | 12 | |
| 846 | CR2/TNFRSF13B ratio | PRORT000738 | 2.34 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 847 | CDC37/PPP1R12A ratio | PRORT000540 | 2.34 | Protein ratios | Muscle / cardiac | 1 | 3 | 10 | 19 | |
| 848 | Cholesterol, HDL | LIPID000003 | 2.34 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 849 | SPOCK1 levels | PROLV001934 | 2.33 | Protein levels | Neural / glial | 61 | 4 | 9 | 10 | |
| 850 | C2/LILRB4 ratio | PRORT000264 | 2.32 | Protein ratios | Myeloid | 71 | 3 | 11 | 24 | |
| 851 | Cholesterol, HDL free | LIPID000001 | 2.32 | Lipids | Hepatocyte | 1,923 | 3 | 8 | 19 | |
| 852 | Medication, ACE inhibitor | VASCU000028 | 2.32 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 853 | ICA1/TANK ratio | PRORT001320 | 2.31 | Protein ratios | Neural / glial | 0 | 3 | 4 | 9 | |
| 854 | CMIP levels | PROLV000470 | 2.31 | Protein levels | Stromal / connective | 1 | 2 | 6 | 11 | |
| 855 | SPARCL1 levels | PROLV001924 | 2.31 | Protein levels | Hepatocyte | 112 | 2 | 9 | 18 | |
| 856 | Ovarian cyst | REPRO000022 | 2.31 | Reproductive | Pancreatic epithelium | 32 | 0 | 5 | 7 | |
| 857 | Alport syndrome | NEPHR000003 | 2.31 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 858 | PNLIPRP2 levels | PROLV001593 | 2.30 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 859 | ADHD | PSYCH000033 | 2.30 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 860 | BACH1/CD2AP ratio | PRORT000191 | 2.30 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 | |
| 861 | Spine surgery | MSKEL000051 | 2.30 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 862 | Diabetes, with complication | METBL000035 | 2.30 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 863 | Skin ulcer | DERMA000044 | 2.29 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 864 | Phospholipids, HDL | LIPID000048 | 2.29 | Lipids | Hepatocyte | 2,061 | 3 | 9 | 16 | |
| 865 | ANGPTL3 levels | PROLV000097 | 2.29 | Protein levels | Hepatocyte | 67 | 1 | 10 | 15 | |
| 866 | CCL8 levels | PROLV000300 | 2.29 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 867 | SERPINA3 levels | PROLV001817 | 2.29 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 868 | USO1 levels | PROLV002144 | 2.29 | Protein levels | Platelet | 10 | 4 | 7 | 19 | |
| 869 | SLA2 levels | PROLV001874 | 2.28 | Protein levels | Stromal / connective | 21 | 4 | 5 | 9 | |
| 870 | ERP44 levels | PROLV000732 | 2.28 | Protein levels | Hepatocyte | 67 | 6 | 14 | 38 | |
| 871 | GLA levels | PROLV000893 | 2.28 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 872 | CELA3A/CPB1 ratio | PRORT000594 | 2.28 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 873 | Dementia | NEURO000019 | 2.27 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 874 | Hippocampal volume | NIMAG000024 | 2.26 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 875 | Vitreous disorder | OPHTH000047 | 2.26 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 876 | PPP1R2 levels | PROLV001616 | 2.26 | Protein levels | Vascular | 8 | 4 | 8 | 19 | |
| 877 | PRTN3/RETN ratio | PRORT001711 | 2.26 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 878 | SVEP1 levels | PROLV001982 | 2.25 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 879 | PON2 levels | PROLV001601 | 2.25 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 880 | MSRA/PRDX5 ratio | PRORT001562 | 2.25 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 881 | DECR1/MAP2K6 ratio | PRORT000882 | 2.25 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 882 | GMFG levels | PROLV000901 | 2.25 | Protein levels | Myeloid | 17 | 4 | 9 | 23 | |
| 883 | CEP43/WASF1 ratio | PRORT000603 | 2.25 | Protein ratios | Myeloid | 0 | 1 | 7 | 11 | |
| 884 | CHMP1A levels | PROLV000431 | 2.24 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 885 | FCGR2B levels | PROLV000779 | 2.24 | Protein levels | Myeloid | 47 | 1 | 8 | 18 | |
| 886 | APP/LAMA4 ratio | PRORT000127 | 2.24 | Protein ratios | Lymphocyte | 7 | 3 | 9 | 26 | |
| 887 | Bowel function | GASTR000002 | 2.24 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 888 | Heme malignancy, Plasma cell | MALIG000046 | 2.23 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 889 | DCTN1/FXN ratio | PRORT000872 | 2.23 | Protein ratios | Hepatocyte | 0 | 4 | 15 | 34 | |
| 890 | Optic disc area | OPHTH000029 | 2.23 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 891 | Gut microbial pathway abundance | GASTR000038 | 2.23 | Gastrointestinal | Hepatocyte | 0 | 3 | 9 | 26 | |
| 892 | GRAP2/SNX9 ratio | PRORT001245 | 2.23 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 893 | CFH levels | PROLV000413 | 2.23 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 894 | DFFA levels | PROLV000615 | 2.23 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 895 | CALCOCO1/PDLIM7 ratio | PRORT000300 | 2.22 | Protein ratios | Myeloid | 1 | 3 | 11 | 27 | |
| 896 | Latent factor, red cell and basophil | HEMAT000037 | 2.22 | Hematologic | Lymphocyte | 2 | 0 | 2 | 8 | |
| 897 | ANXA3/ANXA4 ratio | PRORT000103 | 2.21 | Protein ratios | Myeloid | 0 | 3 | 10 | 14 | |
| 898 | Potassium | METAB000049 | 2.20 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 899 | DCXR/GSTA1 ratio | PRORT000876 | 2.20 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 900 | FAP/THBS4 ratio | PRORT001117 | 2.20 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 901 | Medication, anti-obesity | METBL000026 | 2.19 | Metabolic | Neural / glial | 0 | 1 | 4 | 11 | |
| 902 | Cancer, Breast | MALIG000011 | 2.19 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 903 | GOPC levels | PROLV000910 | 2.19 | Protein levels | Myeloid | 27 | 1 | 7 | 15 | |
| 904 | PLXNA4/VASH1 ratio | PRORT001689 | 2.19 | Protein ratios | Myeloid | 4 | 6 | 15 | 24 | |
| 905 | GFER levels | PROLV000875 | 2.19 | Protein levels | Muscle / cardiac | 1 | 4 | 11 | 27 | |
| 906 | AGRN levels | PROLV000057 | 2.18 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 907 | DECR1/STX8 ratio | PRORT000884 | 2.18 | Protein ratios | Hepatocyte | 9 | 2 | 8 | 15 | |
| 908 | SERPINA11 levels | PROLV001815 | 2.18 | Protein levels | Hepatocyte | 203 | 1 | 7 | 13 | |
| 909 | MED18/SH2B3 ratio | PRORT001508 | 2.17 | Protein ratios | Hepatocyte | 5 | 5 | 8 | 30 | |
| 910 | KLK11 levels | PROLV001152 | 2.17 | Protein levels | Myeloid | 26 | 1 | 4 | 12 | |
| 911 | Parental longevity | AGING000003 | 2.16 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 912 | Otitis externa | AUDIO000003 | 2.16 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 913 | ADGRB3 levels | PROLV000040 | 2.16 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 914 | Hospital discharge | MISCL000023 | 2.16 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 915 | Insulin resistance | METBL000041 | 2.15 | Metabolic | Hepatocyte | 4 | 1 | 5 | 10 | |
| 916 | ADGRG2/NRCAM ratio | PRORT000036 | 2.15 | Protein ratios | Epithelial | 20 | 3 | 10 | 12 | |
| 917 | Triglycerides | LIPID000039 | 2.15 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 918 | STX4 levels | PROLV001968 | 2.15 | Protein levels | Vascular | 9 | 3 | 8 | 15 | |
| 919 | MITD1/SNX9 ratio | PRORT001537 | 2.14 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 920 | IL6ST/PDGFRA ratio | PRORT001356 | 2.14 | Protein ratios | Myeloid | 19 | 2 | 7 | 24 | |
| 921 | DOK2/PPP1R2 ratio | PRORT000942 | 2.14 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 19 | |
| 922 | FKBP5/ZBTB16 ratio | PRORT001160 | 2.14 | Protein ratios | Muscle / cardiac | 21 | 1 | 4 | 12 | |
| 923 | Coagulation disorder | HEMAT000017 | 2.13 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 924 | ERBB4/F3 ratio | PRORT001046 | 2.13 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 925 | EFNB2 levels | PROLV000683 | 2.12 | Protein levels | Hepatocyte | 9 | 0 | 3 | 6 | |
| 926 | FAM13A levels | PROLV000759 | 2.12 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 927 | CRELD2/HYOU1 ratio | PRORT000756 | 2.12 | Protein ratios | Granulosa cell | 19 | 1 | 6 | 2 | |
| 928 | Abdominal adiposity | BCOMP000003 | 2.11 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 929 | TBCB levels | PROLV001999 | 2.11 | Protein levels | Platelet | 7 | 6 | 10 | 17 | |
| 930 | Acylcarnitines | METAB000038 | 2.11 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 931 | Chloride | METAB000044 | 2.07 | Metabolites | Hepatocyte | 527 | 0 | 6 | 11 | |
| 932 | CCN2/TPP1 ratio | PRORT000370 | 2.07 | Protein ratios | Myeloid | 57 | 3 | 8 | 16 | |
| 933 | CTSF/CTSV ratio | PRORT000800 | 2.07 | Protein ratios | Hepatocyte | 55 | 1 | 7 | 9 | |
| 934 | C2 levels | PROLV000230 | 2.07 | Protein levels | B / plasma cell | 63 | 2 | 10 | 16 | |
| 935 | PEAR1/SPINT2 ratio | PRORT001660 | 2.07 | Protein ratios | Platelet | 3 | 2 | 6 | 20 | |
| 936 | IL2RB levels | PROLV001070 | 2.06 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 937 | Benign neoplasm, Salivary gland | MALIG000006 | 2.06 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 938 | Oestrogen metabolite | ENDOC000009 | 2.05 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 939 | Cirrhosis | HPBIL000006 | 2.05 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 940 | TNFSF12 levels | PROLV002077 | 2.05 | Protein levels | Lymphocyte | 61 | 2 | 7 | 31 | |
| 941 | PRDX3 levels | PROLV001625 | 2.05 | Protein levels | Myeloid | 11 | 2 | 7 | 12 | |
| 942 | AXIN1/SRPK2 ratio | PRORT000177 | 2.04 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 943 | LAT/LYN ratio | PRORT001422 | 2.04 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 944 | Triglycerides, IDL | LIPID000034 | 2.04 | Lipids | Hepatocyte | 918 | 2 | 9 | 15 | |
| 945 | AHCY/HSPA1A ratio | PRORT000055 | 2.03 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 946 | ITGA6 levels | PROLV001107 | 2.03 | Protein levels | Myeloid | 24 | 2 | 6 | 15 | |
| 947 | CALB1 levels | PROLV000253 | 2.03 | Protein levels | Hepatocyte | 6 | 1 | 10 | 15 | |
| 948 | Triglycerides, LDL | LIPID000035 | 2.01 | Lipids | Hepatocyte | 1,174 | 2 | 10 | 12 | |
| 949 | Severe mental illness | PSYCH000017 | 2.01 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 950 | PSRC1 levels | PROLV001662 | 2.01 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 951 | CD163/IL18BP ratio | PRORT000382 | 2.00 | Protein ratios | Myeloid | 12 | 2 | 11 | 20 | |
| 952 | BSG/PCDH1 ratio | PRORT000250 | 2.00 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 953 | S100A11 levels | PROLV001766 | 2.00 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 954 | ALOX15B levels | PROLV000081 | 1.99 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 955 | AXIN1/INPPL1 ratio | PRORT000172 | 1.98 | Protein ratios | Granulosa cell | 1 | 3 | 9 | 11 | |
| 956 | ALCAM/ENPP2 ratio | PRORT000070 | 1.98 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 957 | DECR1/METAP1D ratio | PRORT000883 | 1.98 | Protein ratios | Muscle / cardiac | 0 | 1 | 5 | 13 | |
| 958 | CMC1 levels | PROLV000469 | 1.98 | Protein levels | Stromal / connective | 28 | 2 | 5 | 14 | |
| 959 | P4HB/PPP1R12A ratio | PRORT001618 | 1.97 | Protein ratios | Muscle / cardiac | 13 | 5 | 11 | 24 | |
| 960 | Spondylopathy | MSKEL000080 | 1.97 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 961 | Brugada syndrome | CARDI000020 | 1.97 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 962 | PODXL2/SDC1 ratio | PRORT001696 | 1.97 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 963 | SPARC levels | PROLV001923 | 1.96 | Protein levels | Myeloid | 35 | 1 | 8 | 12 | |
| 964 | HSD11B1/SMPD1 ratio | PRORT001302 | 1.96 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 965 | CCL25 levels | PROLV000292 | 1.96 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 966 | Chronic kidney disease | NEPHR000001 | 1.95 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 967 | GP2/SELE ratio | PRORT001231 | 1.95 | Protein ratios | Pancreatic epithelium | 13 | 0 | 4 | 10 | |
| 968 | LGALS7 or LGALS7B levels | PROLV001205 | 1.95 | Protein levels | Respiratory epithelium | 79 | 1 | 11 | 12 | |
| 969 | CST3/EFEMP1 ratio | PRORT000782 | 1.94 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 15 | |
| 970 | Supplement use, glucosamine | DTSUP000025 | 1.94 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 971 | Hearing loss, sensorineural | AUDIO000008 | 1.94 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 972 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 1.94 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 973 | COLEC12/TAFA5 ratio | PRORT000706 | 1.94 | Protein ratios | B / plasma cell | 13 | 1 | 6 | 11 | |
| 974 | Cholesterol, LDL free | LIPID000006 | 1.93 | Lipids | Hepatocyte | 1,130 | 1 | 8 | 11 | |
| 975 | SPINK1 levels | PROLV001927 | 1.92 | Protein levels | Pancreatic epithelium | 75 | 0 | 6 | 9 | |
| 976 | S100A16 levels | PROLV001770 | 1.91 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 977 | LEPR/NRCAM ratio | PRORT001447 | 1.91 | Protein ratios | Epithelial | 23 | 1 | 13 | 18 | |
| 978 | Surgical history | MISCL000031 | 1.91 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 979 | Endometriosis | REPRO000005 | 1.90 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 980 | PAMR1 levels | PROLV001493 | 1.90 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 981 | Operation, reproductive | REPRO000042 | 1.90 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 982 | MITD1/WWP2 ratio | PRORT001538 | 1.89 | Protein ratios | Hepatocyte | 0 | 3 | 16 | 32 | |
| 983 | Iron content, Pancreas | METBL000017 | 1.89 | Metabolic | Muscle / cardiac | 0 | 0 | 2 | 11 | |
| 984 | Phospholipids, VLDL | LIPID000051 | 1.88 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 985 | BACH1 levels | PROLV000173 | 1.88 | Protein levels | Myeloid | 10 | 2 | 7 | 12 | |
| 986 | TACC3 levels | PROLV001988 | 1.88 | Protein levels | Myeloid | 46 | 1 | 4 | 13 | |
| 987 | GP2 levels | PROLV000915 | 1.88 | Protein levels | Pancreatic epithelium | 17 | 0 | 4 | 6 | |
| 988 | C1QTNF1/COL4A1 ratio | PRORT000263 | 1.87 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 989 | Study participation | BEHAV000004 | 1.87 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 990 | SNAP23/TXLNA ratio | PRORT001795 | 1.86 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 991 | Brain general volume | NIMAG000015 | 1.86 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 992 | Gut microbial abundance, Rubneribacter | GASTR000035 | 1.86 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 993 | TCTN3 levels | PROLV002005 | 1.86 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 994 | CDON levels | PROLV000385 | 1.86 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 995 | FHIT/GLOD4 ratio | PRORT001144 | 1.85 | Protein ratios | Lymphocyte | 0 | 1 | 6 | 29 | |
| 996 | Gout | METBL000043 | 1.85 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 997 | ENO2/MANF ratio | PRORT001025 | 1.85 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 15 | |
| 998 | PSRC1/SMAD1 ratio | PRORT001714 | 1.85 | Protein ratios | Muscle / cardiac | 1 | 3 | 13 | 28 | |
| 999 | Secondary arthropathy | MSKEL000021 | 1.84 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 1000 | Memory function | PSYCH000007 | 1.84 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 |